Stockwinners Market Radar for March 08, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:21 EST Caribou Biosciences to present preclinical data on CB-011 at AACR - Caribou Biosciences "announced that preclinical data from CB-011, its allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma, or r/r MM, will be presented as a poster at the upcoming American Association for Cancer Research Annual Meeting 2022, held April 8-13, 2022 in New Orleans. CB-011 is the first allogeneic CAR-T cell therapy immune-cloaked to prevent both T- and NK-mediated immune cell rejection. This allogeneic anti-BCMA CAR-T cell therapy is engineered using Cas12a chRDNA technology to insert a BCMA-specific CAR into the TRAC gene and armor the cells with an immune cloaking strategy that includes a knockout of the endogenous B2M gene and site-specific insertion of a B2M-HLA-E fusion transgene into the B2M gene. Caribou is conducting Investigational New Drug-enabling studies to support a planned IND application submission in 2022 for CB-011 in r/r MM."

18:41 EST SPDR Gold Shares holdings rise from 1,062.3MT to 1,067.3MT - This is the third consecutive increase and the highest level of holdings since March of 2021.

18:10 EST C4 Therapeutics' treatment of soft tissue sarcoma granted FDA orphan designation - According to a post on the FDA's websigte, C4 Therapeutics' treatment of soft tissue sarcoma was granted FDA orphan designation. Reference Link

18:06 EST P.A.M. Transportation to retire treasury shares and announces stock split - P.A.M. Transportation Services announced that the Company's Board of Directors approved a resolution to retire the Company's current treasury share holdings and declared a 2-for-1 forward stock split of its common stock. The Company currently holds approximately 12.3M treasury shares that will be retired immediately. The stock split will be in the form of a 100% stock dividend and is payable on March 29 to stockholders of record on March 18. Under the terms of the stock split, the Company's stockholders will receive a dividend of one share for every share held on the record date. The dividend will be paid in authorized but unissued shares of common stock of the Company. The additional shares will be distributed by the Company's transfer agent, Computershare, and the per share price of the Company's common stock will adjust accordingly on The Nasdaq Stock Market. The Company expects trading will begin on a split-adjusted basis on March 30.

18:02 EST Deluxe sells Australia web hosting business to Newfold Digital, no terms - Newfold Digital announced it has entered into a definitive agreement with Deluxe to acquire Deluxe's Australia web hosting business, Hostopia Australia. The transaction is expected to close in the second quarter of 2022 subject to the satisfaction of customary closing conditions. The Deluxe Australia web hosting business serves as a trusted hosting provider to more than 50,000 small business customers and hosts 250,000 websites. "Newfold Digital's mission is centered on helping businesses of all sizes build and grow an online presence, so we are confident our Australia web hosting customers will be in good hands," said Garry Capers, President of Cloud Solutions for Deluxe. "Throughout our ongoing transformation, Deluxe has concentrated our efforts on cross selling our many platforms, solutions and services to our four million small business customers and more than 4,000 enterprise and financial customers. To better manage our portfolio of businesses, and to emphasize our cross-sell abilities, it makes sense at this time to sell our Australia hosting operations to further refine our offerings in the North American market."

17:57 EST Caesars CEO Reeg acquires 10,000 common shares - In a regulatory filing, Caesars Entertainment CEO Thomas Reeg disclosed the purchase of 10,000 common shares of the company on March 8 at a price of $71.3755 per share.

17:42 EST Civeo VP Schoening sells $117K in company shares - Civeo VP Allan Schoening sold 5,000 shares of company stock at $23.41 on March 7, for a total transaction amount of $117,061.

17:38 EST W&T Offshore sees Q1 total production 3,120-3,450 MBoe - Sees Q1 average daily equivalents 34.6-38.3 MBoe/d.

17:35 EST Ford Pro launches six new home and depot chargers - Ford Pro is aiming to create a smooth transition for commercial customers into an electric future by providing a one-stop shop for fleet operations and investing in key areas of the business. The latest is the launch of six new home and depot chargers to its end-to-end portfolio of charging solutions.Ford Pro is pulling the wraps off a wide range of charging hardware - from home chargers to large-scale depot charging systems - all backed with integrated installation, software, service and Ford Pro FinSimple financing. Ford Pro charging hardware launches alongside the all-new 2022 Ford E-Transit shipping to dealers now and the all-new 2022 Ford F-150 Lightning Pro arriving this spring, providing compatibility for customers who may operate other electric vehicle makes with secure OEM data. "We are investing heavily in products and services to help commercial customers accelerate into an electric future, which means helping to ensure our hardware and software can plug and play with other manufacturers, as we know many customers operate mixed-make fleets," said Ted Cannis, Ford Pro CEO. "These chargers can be completely customized to unique commercial environments and can work even better when paired together with Ford Pro electric vehicles and Telematics to enable OEM-grade data transparency."

17:27 EST Stitch Fix says higher dormancies led to lower active clients for the quarter - Says net active clients to remain flat to down quarter-over-quarter in Q3. Says FY22 guidance assumes active clients are flat for the rest of the year. Says disappointed not showing growth for Q3 and FY22. Says expects to increase marketing as conversion improves. Says efforts will take time. Says created friction when adding Freestyle to the landing page. Says testing newer and improved landing pages. Says testing incentives. Says opening new marketing channels. Says Q3 is going to be similar to Q3 of last year in terms of advertising. Comments taken from Q2 earnings conference call.

17:19 EST Medallion Financial to resume Stock Repurchase Program - Medallion Financial announced it would resume its existing Stock Repurchase Program. Under the repurchase program previously authorized by the board of directors, Medallion Financial may repurchase its outstanding shares of common stock from time to time in open market or privately-negotiated transactions, including accelerated share repurchase transactions, block trades, or pursuant to 10b5-1 trading plans. The Company has $22.9M available under the current program. As of its most recently reported quarter-end December 31, 2021, the Company has 25,173,386 shares outstanding.

17:12 EST Casey's General Stores backs FY22 outlook for fuel and inside sales - The Company is "reiterating its FY22 outlook, previously disclosed in the second quarter. The Company expects same-store fuel and inside sales to increase by mid-single digit percentages for the fiscal year. Total operating expenses for the year are expected to increase high-teen percentages. For the fourth quarter, operating expenses are expected to increase 11-13%. The Company expects to add approximately 225 units during fiscal 2022. Interest expense is expected to be approximately $55M. Depreciation and amortization is expected to be approximately $310M and the purchase of property and equipment is expected to be approximately $400M. The tax rate is expected to be approximately 24.0% - 26.0% for the year."

17:10 EST PayPal suspends services in Russia - In a regulatory filing, the company stated, "With respect to the military hostilities commenced by Russia in Ukraine, our priority is the safety and well-being of our PayPal employee community impacted by these events. We continue to take actions to comply with all applicable restrictions and sanctions that may impact our operations. We have suspended PayPal services in Russia. We are unable to reasonably estimate the total potential financial impact that may ultimately result from this situation. In 2021, our total net revenues related to Russia and Ukraine were approximately one-half of one percentage point (50 basis points) of our total consolidated net revenues."

17:03 EST Schlumberger launches business to eliminate Oil and Gas Industry's emissions - Schlumberger "announced the launch of Schlumberger End-to-end Emissions Solutions, or SEES. The business offers a comprehensive set of services and cutting-edge technologies designed to give operators a robust and scalable solution for measuring, monitoring, reporting and, ultimately, eliminating methane and routine flare emissions from their operations. SEES launches at a critical time in the industry-today we witnessed leadership from Oil and Gas Climate Initiative (OGCI) members who announced their aim for zero methane gas emissions in oil and gas operations by 2030. Methane and flare emissions currently account for more than 60% of direct greenhouse gas emissions from the industry."

17:00 EST Toll Brothers raises quarterly dividend by 18% to 20c per share - The dividend will be paid on April 22, 2022 to shareholders of record on the close of business on April 8, 2022.

16:51 EST Kinetik Holdings drops 8% to $63.90 after announcing 2.5M secondary offering

16:50 EST Civitas Solutions to pay Q1 dividend of $1.2125 per share - The company's board of directors has elected to pay a dividend of $1.2125 per share in the first quarter, which reflects the combination of a variable dividend of 75c a share and a base dividend of 46.25c a share. This dividend will be paid on March 30 to shareholders of record as of March 18.

16:43 EST Stitch Fix drops 16% to $9.20 after lowering FY22 revenue guidance

16:37 EST Paratek announces data from NUZYRA study for MAC, pulmonary infection published - Paratek Pharmaceuticals announced the publication of data from an investigator-initiated study evaluating the activity of NUZYRA or omadacycline, in a dynamic hollow fiber model of Mycobacterium avium complex, MAC, pulmonary infection. The investigator-initiated study conducted by Chapagain et al. entitled "Omadacycline efficacy in the hollow fibre system model of pulmonary Mycobacterium avium complex and potency at clinically attainable doses" was supported by a research grant from Paratek and published in the Journal of Antimicrobial Chemotherapy. The authors determined that NUZYRA demonstrated considerable efficacy and potency against MAC when tested in a hollow fiber system infection model at the standard clinical doses approved for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in adults. Subsequent simulations conducted to identify the optimal dose of oral omadacycline predicted that standard clinical doses would be bactericidal in the treatment of pulmonary MAC. "In this study, we confirmed our hypothesis that NUZYRA, because of its known spectrum of activity, would demonstrate activity against MAC in this infection model," said investigator Tawanda Gumbo, M.D., chief executive officer of Praedicare, Inc. "Based on the impressive results showing the highest NUZYRA exposure produced a similar reduction in mycobacterial burden as a three-drug standard of care regimen consisting of clarithromycin plus rifabutin and ethambutol, we believe further research is warranted to determine the potential of NUZYRA as a treatment option for pulmonary NTM infections caused by MAC."

16:33 EST Amgen to present long-term outcomes for LUMAKRAS in NSCLC - Amgen "announced that new data from across its oncology portfolio and pipeline will be presented at the American Association for Cancer Research Annual Meeting from April 8-13 in New Orleans, Louisiana. Long-term outcomes from the CodeBreaK 100 trial of LUMAKRAS, or sotorasib, the first and only KRASG12C inhibitor approved for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer, or NSCLC, will be shared as a late-breaking oral presentation on Sunday, April 10, 2022 from 3:00 - 5:00 p.m. CST. Notable data from Amgen's oncology pipeline includes the first disclosure of preclinical results from AMG 794, a half-life extended bispecific T-cell engager molecule targeting Claudin 6 in NSCLC and epithelial ovarian cancer, and TNB-928b, a T-cell engaging bispecific antibody utilizing a bivalent tumor-selective folate receptor alpha binding arm for the treatment of ovarian cancer."

16:31 EST TEN announces 24-month charter extension of two panamax tankers - TEN announced the 24-month extension to the charter of two panamax tankers with the existing charterer, a leading South American oil concern. The employment, at an accretive floor rate with favorable upside optionality, is expected to generate minimum gross revenues of about $25 million over the duration of the respective contracts. "Long-term continuity is in the core of TEN's commercial strategy with the establishment and expansion of solid partnerships," Mr. George Saroglou, COO of TEN commented. "In today's uncertain environment, such strategy ensures full fleet utilization and upside potential, directly reflected on the Company's bottom line," Mr. Saroglou concluded.

16:25 EST Jack Henry COO Adelson sells 4,400 common shares - In a regulatory filing, Jack Henry president and COO Gregory Adelson disclosed the sale of 4,400 common shares of the company on March 7 at a price of $185.2295 per share.

16:24 EST PepsiCo suspends sale of Pepsi-Cola, other drinks in Russia - In a letter from CEO Ramon Laguarta to PepsiCo associates posted to the company's site, the executive stated in part: "As the tragic war continues in Ukraine, I wanted to update everyone on PepsiCo's activities in the region. As many of you know, we have been operating in Russia for more than 60 years, and we have a place in many Russian homes. Pepsi-Cola entered the market at the height of the Cold War and helped create common ground between the United States and the Soviet Union. However, given the horrific events occurring in Ukraine we are announcing the suspension of the sale of Pepsi-Cola, and our global beverage brands in Russia, including 7Up and Mirinda. We will also be suspending capital investments and all advertising and promotional activities in Russia. As a food and beverage company, now more than ever we must stay true to the humanitarian aspect of our business. That means we have a responsibility to continue to offer our other products in Russia, including daily essentials such as milk and other dairy offerings, baby formula and baby food. By continuing to operate, we will also continue to support the livelihoods of our 20,000 Russian associates and the 40,000 Russian agricultural workers in our supply chain as they face significant challenges and uncertainty ahead. Our first priority continues to be the safety and security of our fellow Ukrainian associates. We suspended operations in Ukraine to enable our associates to seek safety for themselves and their families, and our dedicated crisis teams in the sector and region continue to closely monitor developments in real time... My heart goes out to all those who are caught in the middle of this deadly conflict. As it so often does, war is falling hardest on the innocent. War is never an answer, and we join all those calling for a speedy, peaceful resolution." Reference Link

16:20 EST CytoSorbents sees gradual recovery of normalized hospital activity in FY22 - The company said, "The macro environment in which we operate remains difficult to predict given the complex drivers of our business and global nature of our operations. We expect COVID-19 cases and hospitalizations worldwide to continue to decline and expect to reach a more normalized operating environment as the year progresses, as high rates of vaccination and natural immunity have reduced the severity of COVID-19 illness and need for hospitalization and ICU care, and with it the use of CytoSorb in these patients. Our 2022 outlook assumes a gradual recovery of normalized hospital activity in Germany and other key countries and no major economic slowdowns as a result of new variants of COVID-19. As a result, we expect limited COVID-19 related product sales in 2022 compared to an estimated $6.3M in COVID-19 related product sales in 2021. In addition, given our global presence, the Russia-Ukraine war presents a unique challenge, and we are unable to predict at this time how this situation may evolve. We believe we currently have limited exposure, where in 2021, product sales generated from Russia and neighboring countries potentially impacted by the conflict amounted to less than 4% of product revenue. Assuming little, to no sales in 2022 from Russia and neighboring countries that might be impacted by the war, we expect growth of 20% or more in 2022 core, non-COVID-19 sales, compared to $33.8M in core, non-COVID-19 product sales generated in 2021."

16:15 EST Adams Resources to expand and enhance quality of service in FY22 - Kevin J. Roycraft, Adams' CEO, commented "Our focus for 2022 is to continue to expand and enhance the quality of the service offerings we provide for our customers. Our plans are multi-faceted in nature and span all of our business units. At GulfMark, we remain squarely focused on driving incremental efficiencies in our fleet operations. We are executing on a number of identified opportunities in the business designed to generate additional free cash flow. This complements our efforts at Service Transport where we continue to enhance our truck utilization, fleet utilization and driver retention and recruitment efforts. We also look forward to further expansion of our VEX Pipeline System through new connection opportunities that drive increased pipeline and storage utilization. Supporting our expansion efforts is our continued strong financial position supported by a year-end 2021 cash balance of $98M and available borrowing balance on our credit facility of $34M, resulting in almost $132M of liquidity for the Company at the end of last year. As such, we remain in a great position to continue to capitalize on both internal and external opportunities that drive further cash flow generation that supports the long-term needs of our shareholders."

16:13 EST XPO Logistics backs prior Q1 guidance - XPO reiterated its first quarter and full year 2022 guidance issued February 8.

16:12 EST XPO Logistics announces plan to create two standalone, public companies - XPO Logistics announced that its board of directors, after a thorough examination of strategic alternatives, has approved a plan that the board believes is the optimal path to unlock value for XPO stakeholders. XPO intends to separate its tech-enabled brokered transportation services from its less-than-truckload (LTL) business in North America; and intends to divest its European business and North American intermodal operation. The planned spin-off transaction is intended to be tax-free to XPO shareholders and would create two focused, publicly traded companies at the top of their industries: The spin-off would be a leading platform for tech-enabled truck brokerage services in North America, with a long track record of industry-best revenue and margin growth, a highly efficient digital freight marketplace and access to vast truckload capacity, with complementary, asset-light offerings for last mile logistics, managed transportation and global forwarding. The corporate headquarters are expected to be in Charlotte, North Carolina Upon completion of the spin-off, XPO's North American LTL segment would be a pure-play LTL industry leader - the third largest provider of domestic and cross-border LTL freight shipping, with a competitively advantaged network of transportation assets managed by proprietary technology. The standalone business would have a singular focus on enhancing the growth and profitability of its national network for the benefit of its stakeholders. The corporate headquarters are expected to be in Greenwich, Connecticut. The company plans to divest its European business through either a sale or a listing on a European stock exchange. In North America, the company is currently under an exclusivity agreement in connection with a potential sale of its intermodal business, which provides rail brokerage and drayage services. Brad Jacobs, chairman and chief executive officer of XPO Logistics, said, "Our two core businesses of North American less-than-truckload and tech-enabled truck brokerage are industry-leading platforms in their own right, each with a distinct operating model and a high return on invested capital. We believe that by separating these businesses through a spin-off, we can significantly enhance value creation for our customers, employees and shareholders, as we did with our successful spin-off of GXO last year." The company expects to complete the planned spin-off in the fourth quarter of 2022, subject to various conditions, including the effectiveness of a Form 10 registration statement, receipt of a tax opinion from counsel, the refinancing of XPO's debt on terms satisfactory to the XPO board of directors, and final approval by the XPO board of directors, among other requirements. There can be no assurance that the planned spin-off or divestiture transactions will occur or, if one or more do occur, of the terms or timing.

16:12 EST Bumble discontinuing operations in Russia - Bumble announced that it is discontinuing its operations in Russia, as well as removing all of its apps from the Apple App Store and Google Play Store in Russia and Belarus. The combined revenue from Russia, Ukraine, and Belarus was approximately 2.8% of total Bumble annual revenue in 2021, almost all in Badoo App and Other revenue. Russia, Belarus, and Ukraine contribute less than 0.1% of Bumble App revenue.

16:10 EST MongoDB reports Q4 subscription revenue $258.2M, up 58% y/y - Q4 services revenue was $8.3M, an increase of 17% year-over-year.

16:06 EST SCVX Corp (Class A Stock) trading halted, news pending

15:53 EST Coca-Cola says Russia, Ukraine contributed 1%-2% of 2021 operating income - In a regulatory filing, Coca-Cola said: "On March 8, 2022, The Coca-Cola Company announced that it is suspending its business in Russia. While the impact to the company is not yet fully known, as a point of reference, in 2021, the company's business in Russia and Ukraine contributed approximately 1% to 2% of the company's consolidated net operating revenues and operating income. In addition, as of December 31, 2021, the company had an approximate 21% ownership interest in Coca-Cola HBC AG, the company's bottling and distribution partner in the region. Given the rapidly changing conditions in these markets, the company will continue to monitor and assess the situation as circumstances evolve."

15:38 EST Generac temporarily suspends branch operations and sales in Russia - Generac announced that, effective immediately, the company is temporarily suspending its branch operations and sales in Russia. "Generac joins the global community in denouncing the Russian regime's attacks on Ukraine," said Aaron Jagdfeld, president and chief executive officer of Generac. "Our hearts go out to the Ukrainian people, and we stand in solidarity with others around the world in calling for peace." Sales in Russia comprise less than 1% of Generac's total revenue, and the impact on the company's financial results is not expected to be material. Generac does not have any employees stationed in Ukraine.

15:19 EST Shopify temporarily suspends operations in Russia, Belarus - Shopify said that, for the foreseeable future, it will not collect fees from our Ukrainian merchants and partners. In addition, the company is temporarily suspending operations in Russia and Belarus. "We will continue to monitor events on the ground as they evolve and comply with applicable sanctions as they are announced," the company said. Reference Link

15:12 EST Starbucks to immediately pause store operations in Russia - Starbucks posted the following letter to partners from Kevin Johnson on Ukraine to its website: "As I communicated Friday, we condemn the horrific attacks on Ukraine by Russia and our hearts go out to all those affected. We continue to watch the tragic events unfold and, today, we have decided to suspend all business activity in Russia, including shipment of all Starbucks products. Our licensed partner has agreed to immediately pause store operations and will provide support to the nearly 2,000 partners in Russia who depend on Starbucks for their livelihood. Through this dynamic situation, we will continue to make decisions that are true to our mission and values and communicate with transparency. Thank you for the care and concern you are sharing with me and your leaders." Reference Link

14:47 EST Cyren trading resumes

14:42 EST Cyren trading halted, volatility trading pause

14:32 EST Users report issues with Amazon Web Services, DownDetector says - Reference Link

14:02 EST AIM ImmunoTech announces 'positive data' published in peer-reviewed journal - AIM ImmunoTech announced the publication of "positive data" from a single-center named patient program treating advanced and metastatic pancreatic cancer patients. The manuscript titled, "Rintatolimod enhances numbers of peripheral B cells and is associated with longer survival in patients with locally advanced and metastasized pancreatic cancer pre-treated with FOLFIRINOX: a single-center named patient program1," was published in the peer-reviewed journal, Cancers Special Issue: Combination and Innovative Therapies for Pancreatic Cancer. In the single-center named patient program, patients with locally advanced pancreatic cancer or metastatic disease were treated with Ampligen for 6 weeks, at 2 doses per week with 400 mg per infusion. The study found that Ampligen improved the median survival of these patients. The median overall survival in the Ampligen group was 19 months, compared to a historical control group and subgroup of 7.5 and 12.5, respectively, that did not receive Ampligen. The median PFS was significantly longer, or 13 months, with rintatolimod compared to both matched controls and the subset of matched controls at 5 and 8.6 months, respectively. "We are very encouraged by these data, which we believe reaffirm the potential of Ampligen to offer an important treatment option to patients living with pancreatic cancer. These data now in hand play a key role in the overall advancement of our pancreatic cancer program and provide valuable insight as we continue to execute the path forward. We continue to be encouraged by the favorable results demonstrated with Ampligen and are committed to securing the next phase of development of this important program," commented Thomas Equels, CEO of AIM.

13:58 EST Apple unveils new Mac Studio, Studio Display - Apple introduced Mac Studio and Studio Display, "an entirely new Mac desktop and display designed to give users everything they need to build the studio of their dreams." Apple said in a statement: "A breakthrough in personal computing, Mac Studio is powered by M1 Max and the new M1 Ultra, the world's most powerful chip for a personal computer. It is the first computer to deliver an unprecedented level of performance, an extensive array of connectivity, and completely new capabilities in an unbelievably compact design that sits within arm's reach on the desk. With Mac Studio, users can do things that are not possible on any other desktop, such as rendering massive 3D environments and playing back 18 streams of ProRes video.1 Studio Display, the perfect complement to Mac Studio, also pairs beautifully with any Mac. It features an expansive 27-inch 5K Retina display, a 12MP Ultra Wide camera with Center Stage, and a high-fidelity six-speaker sound system with spatial audio. Together, Mac Studio and Studio Display transform any workspace into a creative powerhouse. They join Apple's strongest, most powerful Mac lineup ever, and are available to order today, arriving to customers beginning Friday, March 18."

13:56 EST Walmart announces Spotify promotion for Walmart+ members - Chris Cracchiolo, SVP & GM Walmart+, stated in a post to the company's website: "I'm excited to share that we're kicking Walmart+ up a notch by collaborating with one of the largest streaming platforms, Spotify, to offer a special promotion for Walmart+ members. Starting today, new and existing Walmart+ members will receive six months of Spotify Premium for free. That means our Walmart+ members who haven't previously tried Spotify Premium can enjoy ad-free streaming of millions of songs and podcasts, unlimited skips, the ability to play any song anywhere and the ability to download music for listening offline and on-the-go... And there is even more good news - this time it's around how we continue to recognize our associates... That's why today, I'm excited to announce that all full- and part-time Walmart U.S. associates working in our stores, distribution centers and fulfillment centers are getting a free Walmart+ membership. This new associate benefit is not only our way to say thank you for all they do, but it's also so associates can use our membership, tell us how it's going and ultimately speak to customers about it from personal experience... As we look into the future, Walmart+ will only continue to evolve. Stay tuned for new partnerships, new ways to save and an even more seamless in-store and online experience in the coming months, as we continue to find innovative ways to expand our Walmart+ offerings and reach even more customers." Reference Link

13:52 EST Apple Studio Display to come with three USB-C ports, one thunderbolt port - Says Studio Display has A13 chip and 12 megapixel camera. Says Display also comes with six speakers that support spatial audio.

13:46 EST Air Products to build green liquid hydrogen production facility in Arizona - Air Products announced that it will build, own and operate a 10 metric ton per day facility to produce green liquid hydrogen in Casa Grande, Arizona. The zero-carbon liquid hydrogen facility is expected to be on-stream in 2023 and its product will be sold to the hydrogen for mobility market in California and other locations requiring zero-carbon hydrogen. The facility will use two thyssenkrupp nucera electrolyzers to produce gaseous hydrogen, which will be converted to liquid hydrogen using Air Products' proprietary technology. The site will also include a terminal for distributing product to customer locations throughout California and other markets.

13:44 EST Apple's Mac Studio with M1 Ultra to have 80% faster GPU performance than Mac Pro - Says Mac Studio will have 128GB of unified memory with M1 Ultra. Says Mac Studio with M1 Ultra will have 8TB of SSD capacity.

13:39 EST Apple says Studio Display is an external monitor for Mac Studio desktop - Says new Mac Studio desktop computer will "transform" studio workflows everywhere. Says Mac Studio will have M1 Max and M1 Ultra options.

13:33 EST Apple says MacOS automatically scales with M1 Ultra - Says "thrilled" with transition to M1 Ultra.

13:30 EST Apple says M1 Ultra is two attached M1 Max chips - Says M1 Ultra chip offers 2.5 terabytes per second interprocessor bandwidth. Says M1 Ultra is two attached M1 Max chips. Says comes with 800 gigabyte per second memory bandwidth. Says M1 Ultra offers 128GB of unified memory and comes with 64-core GPU.

13:26 EST Spartan Acquisition Corp. III stockholders approve Allego combination - Spartan Acquisition Corp. III announced that stockholders of record as of January 18, 2022, approved the previously proposed business combination with Allego Holding supported by 94% of the shares of Spartan voted at the special meeting. 74% of total outstanding shares voted. Three proposals were considered and voted upon by Spartan's stockholders at the special meeting, all of which were approved. The formal results of the vote will be included in a Current Report on Form 8-K to be filed by with the U.S. Securities and Exchange Commission by Spartan. Pursuant to the Business Combination, at the closing, Allego will combine with Spartan and the combined company's name will be Allego N.V. Following the closing, Allego's ordinary shares and warrants are expected to trade on the New York Stock Exchange under the ticker symbols "ALLG" and "ALLG.WS," respectively.

13:23 EST Apple says new iPad Air starts at $599 - Says preorders start Friday, available March 18.

13:20 EST Apple says iPadOS 15 comes 'packed' with new features - Says iPad OS 15 users can submit apps to App Store right from iPad.

13:19 EST Apple says 5G coming to new iPad Air - Says new iPad Air comes with liquid retina display, but no ProMotion.

13:18 EST Apple announces new green finishes for iPhone 13 lineup - Apple announced two all-new colors for iPhone 13 Pro and iPhone 13, alpine green and green. The new alpine green iPhone 13 Pro and green iPhone 13 will be available for pre-order this Friday, March 11, with availability starting Friday, March 18, Apple announced.

13:16 EST Apple unveils new iPad Air

13:13 EST Apple says new iPhone SE will have 5G capabilities - Says new iPhone SE to be 26x faster than iPhone 8. Says new iPhone SE comes in three colors and will include "toughest glass" on a smartphone. Says iPhone SE colors include midnight, starlight, and red.

13:09 EST Apple says A15 bionic chip coming to new iPhone SE

13:08 EST Apple introduces new green finishes for iPhone 13 - Says preorders start Friday, orders coming March 18.

12:34 EST Unilever suspends all imports and exports of products into and out of Russia - Unilever issued the following updated public statement on the war in Ukraine: "We continue to condemn the war in Ukraine as a brutal and senseless act by the Russian state. Our business operations in Ukraine have stopped and we are now fully focused on ensuring the safety of our Ukrainian employees and their families, including helping with their evacuation where necessary, and providing additional financial support. We have also committed to donate EUR 5m of essential Unilever products to the humanitarian relief effort. We have suspended all imports and exports of our products into and out of Russia, and we will stop all media and advertising spend. We will not invest any further capital into the country nor will we profit from our presence in Russia. We will continue to supply our everyday essential food and hygiene products made in Russia to people in the country. We will keep this under close review. We join calls for an end to this war and hope that peace, human rights, and the international rule of law will prevail." Reference Link

12:16 EST Huntington Ingalls announces labor contract agreement with United Steelworkers - HII was notified that United Steelworker members at the company's Newport News Shipbuilding division voted in favor of a new labor contract. The new contract took effect Monday and will run through Feb. 7, 2027.

12:00 EST Blend Labs falls -11.3% - Blend Labs is down -11.3%, or -96c to $7.54.

12:00 EST Barnes & Noble Education falls -24.0% - Barnes & Noble Education is down -24.0%, or -$1.15 to $3.64.

12:00 EST Independence Contract Drilling rises 38.8% - Independence Contract Drilling is up 38.8%, or $1.95 to $6.98.

11:20 EST DermTech says cost-benefit study published in Journal of Cutaneous Medicine - DermTech announced earlier today that "SKIN: The Journal of Cutaneous Medicine" has published its original research study, with Daniel M. Siegel, MD, MS as the lead author. The findings outlined in the publication, "Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma," suggests that use of the Pigmented Lesion Assay, or "PLA," to rule out melanoma can minimize avoidable surgical procedures on benign lesions and decrease downstream costs of late-stage melanoma diagnoses, which reduces overall cost of care, the company said. To determine the per member per month net savings of incorporating the PLA into the current care pathway, a Return on Investment model was developed from a U.S. payor perspective. This model predicted annual net savings of $0.54 PMPM for commercial health plans over a three-year period with incorporation of the PLA, according to the company. "This research study is a testament to how the PLA has the potential to reduce costs for health insurance plans and improve patient care by limiting the number of potentially avoidable biopsies. As we continue to leverage genomics to advance melanoma detection and dermatology as a whole, we continue to believe that the PLA has the potential to be incorporated into additional insurance plans," said John Dobak, MD, CEO of DermTech. Reference Link

11:12 EST Wabash, Clarience launch technology alliance for trailer applications - Clarience Technologies and Wabash have launched a new technology alliance focused on trailer applications, including new advanced connectivity applications that will be essential as electric and autonomous vehicles come to market. As a first step, Road Ready advanced trailer telematics systems will become standard equipment on all Wabash dealer stock trailers. Michigan-based Clarience Technologies is the parent company to Truck-Lite, the North American leader in LED lighting solutions for commercial transportation, as well as Road Ready advanced telematics, ECCO Safety Systems, DAVCO filtration solutions and several other technology brands.

11:04 EST Barfresh Food Group Inc trading halted, volatility trading pause

10:24 EST Amazon announces launch of live audio app Amp - Amazon on Tuesday launched Amp, a live audio app that lets users DJ their own radio show. Amazon said in a blog post that Amp attempts to "reimagine radio." Reference Link

10:14 EST Avid Technology expands distribution agreement with Adistec - Avid Technology announced the expansion of its distribution agreement with Adistec Corp. into the U.S. market for audio and video content production technologies. Since initiating their partnership last year in support of business in Latin America, Avid has benefitted from Adistec's ability to accelerate distribution partner logistics, finance and other business processes, keeping Avid on pace with demand for its content creation and management products across television, film, music, and education in that region.

10:02 EST Truist Financial CEO Bill Rogers to become chairman of the board - Truist Financial announced that as part of a planned transition, William "Bill" Rogers Jr., Truist's chief executive officer, will become chairman of the board and Thomas Skains will become lead independent director. Both appointments are effective March 12. Rogers succeeds Kelly King, who will be stepping down from the role of chairman as previously announced. Skains succeeds David Ratcliffe. Both King and Ratcliffe will remain on the board, the company noted.

10:00 EST Mexco Energy trading resumes

10:00 EST Sibanye Stillwater falls -9.8% - Sibanye Stillwater is down -9.8%, or -$2.00 to $18.32.

10:00 EST Desktop Metal rises 11.3% - Desktop Metal is up 11.3%, or 40c to $3.94.

10:00 EST Nine Energy Service rises 90.8% - Nine Energy Service is up 90.8%, or $3.26 to $6.85.

09:55 EST Mexco Energy trading halted, volatility trading pause

09:47 EST Babcock & Wilcox falls -7.5% - Babcock & Wilcox is down -7.5%, or -51c to $6.32.

09:47 EST Innovid falls -10.9% - Innovid is down -10.9%, or -76c to $6.22.

09:47 EST Independence Contract Drilling rises 14.3% - Independence Contract Drilling is up 14.3%, or 72c to $5.75.

09:44 EST Indonesia Energy Corporation Limited trading halted, volatility trading pause

09:38 EST Walmart announces plans for new fulfillment center in southern Pennsylvania - Walmart announces plans for a new fulfillment center in southern Pennsylvania to support the retailer's rapidly increasing supply chain network and eCommerce capabilities. The 1.8M+ square-foot Shippensburg facility will be located at 2281 United Drive and is set to open Spring of 2022, creating up to 600 permanent, full-time jobs across the region.

09:38 EST Starboard issues presentation on Huntsman's 'false, misleading' statements - Starboard Value, one of the largest shareholders of Huntsman Corporation with an ownership interest of approximately 8.8% of the Company's outstanding shares, announced that it has issued a supplemental presentation responding to "various false and misleading statements and mischaracterizations" made by Huntsman in its recent investor presentation. The company noted some highlights which include, "Huntsman's troubling history of missed promises and failed commitments to shareholders. Reality: Huntsman FAILED to deliver on its 2016 Investor Day target by a substantial margin....Reality: Huntsman FAILED to deliver on its promise of growing Adjusted EBITDA organically at a 10% CAGR through 2020...In summary, Huntsman MISSED its 2018 Investor Day target if you looked at it in 2020 AND if you properly looked at it in 2021. Please do not be fooled by the Company's DISINGENUOUS attempts to retroactively revise its promises and obfuscate the truth. Huntsman's poor capital allocation. Reality: Huntsman acquired a healthy Textile Effects business in 2006, NOT in 2011 like its shareholder presentation MISLEADINGLY suggests, DESTROYED the business, and the business has only recently recovered to its original state after 16 years...Huntsman's troubling history of poor governance and compensation practices. Reality: Huntsman added directors to an entrenched Board but DID NOT REFRESH legacy directors...Reality: the Company has a FAILING GRADE on pay-for-performance...Huntsman's troubling history of financial underperformance. Reality: Huntsman's core reporting segments have not changed meaningfully since its IPO...Reality: Huntsman's Adjusted EBITDA margins remain one of the LOWEST among peers. Huntsman's margins HAVE NOT been enhanced and have deteriorated from a 500bps deficit to a 900bps deficit relative to peers since its IPO. Huntsman's troubling history of share price underperformance...Reality: Huntsman DOES NOT have a track record of shareholder value creation and has UNDERPERFORMED both peers and the market across nearly all measurable time periods...Starboard and its slate of highly-qualified, diverse and experienced director nominees. Reality: Starboard and its nominees have a proven track record of creating shareholder value, and have extensive and highly relevant expertise in the chemicals industry...PLEASE DO NOT BE FOOLED BY HUNTSMAN'S MANY MISLEADING, REVISIONIST, AND DISINGENUOUS CLAIMS! HUNTSMAN NEEDS STRONG INDEPENDENT BOARD MEMBERS WHO WILL DEMAND ACCOUNTABILITY. If management is willing to mislead shareholders, we believe management may also be willing to mislead the Board, further emphasizing the dire need for change in the boardroom. Huntsman NEEDS directors that are experienced and independent enough to hold management accountable. Our strong, capable, and independent director nominees WILL NOT BE FOOLED by Huntsman's disingenuous tactics."

09:37 EST Marine Petroleum Trust trading resumes

09:32 EST Oshkosh's McNeilus acquires CartSeeker curbside automation product - McNeilus Truck and Manufacturing, an Oshkosh company, and part of Oshkosh's Commercial segment, has acquired the CartSeeker curbside automation product from Eagle Vision Systems and Waterloo Controls. McNeilus is focused on designing and developing technology and other heavy duty truck advancements that move the waste industry forward. This investment in refuse collection vehicle automation drives that strategy forward.

09:31 EST Houston American Energy trading halted, volatility trading pause

09:22 EST Lexaria Bioscience granted new DehydraTECH patent in Australia - Lexaria Bioscience announced it has been granted a new patent entitled "Compositions Infused with Nicotine Compounds and Methods of Use Thereof." The new Australian patent expands upon Lexaria's international intellectual property rights to apply DehydraTECH enhancement technology to most oral forms of nicotine, including pills, tablets, lozenges, capsules, pouches, gums and sprays. The patent covers many different forms of nicotine including free base nicotine, nicotine salts, polymer resins of nicotine and other forms of nicotine complexes.

09:19 EST Matterport continues global expansion via Guandalini Posicionamento, PARS - Matterport announced that it is expanding its presence in the Brazilian market via two strategic partners, Guandalini Posicionamento and PARS, to offer Matterport's spatial data platform to their enterprise customers in the architecture, engineering, and construction, AEC, markets. These partners will sell the Matterport solution in the region, including Matterport's software-as-a-service subscriptions along with capture services and products. The Matterport solution will allow Brazilian businesses and organizations to create highly accurate digital twins of spaces in the built world. With Matterport 3D digital twins, customers across a variety of industries can use the digital twin to measure, document, manage, and promote their properties online. "By working with distributors that have roots in the local market, we are more effectively addressing the surging demand for Matterport in Brazil," said Jay Remley, Chief Revenue Officer of Matterport. "The Brazilian market has approximately 540 million spaces, and actively expanding in the market represents an important milestone in Matterport's journey to make the world's spaces more valuable and accessible. We're thrilled for the opportunity to help new customers across the globe discover the power of digital twins."

09:17 EST EzFill announces new fleet fueling agreement with SERVPRO - EzFill announced the signing of a new fleet agreement with SERVPRO of Brickell in Miami, Florida. EzFill will provide regularly scheduled fueling to the SERVPRO fleet in Brickell effective immediately, with plans to expand and service additional markets for the franchisor in the near future. "The expansion of EzFill's fleet services to SERVPRO of Brickell further emphasizes the growing demand for our mobile fuel delivery business, and we anticipate serving even more SERVPRO locations in the near future," said Mike McConnell, CEO of EzFill. "The Company has added more than 15 new fleet customers in total since our IPO, and a number of additional agreements are expected to be completed soon."

09:16 EST EnWave sells second 10kW REV machine to Nomad Nutrition - EnWave announced that it has received a second purchase order for a 10kW Radiant Energy Vacuum, REV, machine from Nomad Nutrition to double Nomad's commercial production capacity for Ready-to-Eat adventure meals. Nomad previously signed a royalty-bearing commercial license agreement with EnWave in 2018, and this second purchase order is a result of Nomad's growth in sales and product distribution.

09:14 EST CV Sciences adds +PlusCBD Relief Softgels to its Wellness line - CV Sciences announced the addition of +PlusCBD Relief Softgels to its Wellness line of CBD products, joining our highly successful +PlusCBD Sleep & Calm Gummies. "We believe that +PlusCBD Relief Softgels contain the safest, purest and most effective source of CBD/CBDA available on the market today," said Joseph Dowling, Chief Executive Officer of CV Science. "Our work at CV Sciences centers around the potential for CBD to transform our understanding of health, wellness and pain relief. The +PlusCBD Relief Softgels represent another step in our mission to offer innovative and safe alternatives to improve health, leveraging CBD/CBDA and PEA. Our product development team creates best-in-class, innovative products that suit individual preferences, address need states and help consumers benefit from CBD in the way that works best for them. Our Relief product is now available directly from our website www.pluscbdoil.com and soon from select retailers."

09:13 EST Nokia joins 5G OI Lab to advance technologies - Nokia announced that it has joined the 5G Open Innovation Lab, 5G OI Lab, as a corporate sponsor. Nokia will work with other 5G OI Lab startups and partners to pave the way for enabling 5G-era solutions across industry verticals. Nokia has already engaged in programs with 5G OI Lab, including supporting 5G field experiments to solve real-world challenges in the agricultural industry. Ed Alfonso, EVP and GM of Nokia America's Mobile Networks, said: "5G's lightning-fast speed and ultra-low latency are game changers for wireless connectivity and the plethora of new industry applications it can enable. What's also game changing is how 5G will reach its full potential - which will be achieved through partnerships with industry, academia and government and through ecosystems such as those that 5G Open Innovation Lab has created. Working together, we can prove out new 5G and edge use cases and collaborate directly with the startup community that is dreaming up even bigger applications for 5G. Nokia is dedicated to participating in 5G OI Lab's programs with our industry-leading 5G technology and experts."

09:12 EST Liquidity Services supports Ukraine relief programs - Liquidity Services announced a new relief initiative to provide support to those affected by the conflict in Ukraine. During this time of crisis in Ukraine, Liquidity Services has launched a fundraising campaign to aid in Ukraine relief efforts and is committed to matching all employee and marketplace participant contributions to Mercy Corps to help victims obtain needed resources. It will also directly contribute $25,000 to five Ukraine relief organizations including: Mercy Corps; World Central Kitchen; Global Empowerment Mission; International Committee of the Red Cross; and Global Giving. "With the developing humanitarian crisis in Ukraine, we believe it's our duty to use our platform to support relief and rebuilding efforts. As a global company, we have team members in the area and we want to do everything we can to support them and others during this time," said Bill Angrick, Chairman and CEO.

09:09 EST Valens' Green Roads announce support for Arthritis Foundation - Green Roads, a leading CBD wellness brand and subsidiary of The Valens Company, announced they are an official Supporting Sponsor of the Arthritis Foundation after giving a $120,000 donation to support the organization's pain management initiative to advance improved quality of life for those living with chronic pain. As part of the supporting sponsorship, Green Roads has committed to the Arthritis Foundation's pain initiative to aid in reducing life's painful moments. Green Roads' support of this initiative will help the Foundation establish new tools and resources for pain interferences while expanding a community of support. "As a company, Green Roads is 100% focused on helping people feel better today than they did yesterday," said Tyler Robson, CEO of The Valens Company, Green Roads' parent company. "Supporting the Arthritis Foundation's long-term work and creating products that can provide benefits to millions of arthritis patients align perfectly with our mission and our purpose."

09:08 EST Liquid Media completes acquisition of Digital Cinema United - Liquid Media announced the completion of its acquisition of Digital Cinema United, DCU, which provides content supply chain technology and services supporting independent intellectual property, IP, owners, producers, sales agents, alternative content distributors, downstream media platforms and studios. "In closing this acquisition, Liquid bolsters Phase III of its four-phase business solution engine spanning the end-to-end creative process from inception to monetization," the company said. "We are extremely pleased to have reached this milestone, and to welcome the talented DCU team to the Liquid Media family of companies," said Ronald Thomson, CEO of Liquid. "DCU's established clientele expands the reach of our full solution offering, and supercharges our digital service infrastructure. With best-in-class existing services and global reach, we share a vision of the bigger picture of distribution that we are excited to bring to the market." Liquid Media's Digital Cinema United will continue to provide its digital end-to-end supply chain services and tools to clients across North America, Latin America, Australia, New Zealand, Europe, the Middle East and Africa. Liquid acquired DCU for $11.25M payable in common shares of Liquid, which are scheduled to be paid out to DCU investors across specific performance milestones in three tranches.

09:05 EST Scotts Miracle-Gro sees FY Hawthorne sales declining 15%-25% - The Scotts Miracle-Gro Company lowered its full-year sales guidance for its Hawthorne segment and said the reduction would likely lead to adjusted earnings per share that are lower than previously expected. Speaking at the Raymond James 43rd Annual Institutional Investors Conference, chief financial officer Cory Miller said the Company now expects Hawthorne sales to decline 15 to 25 percent, including the benefit of acquisitions. Sales in the segment have been challenged for several months due to an oversupply of cannabis, which is leading to a slowdown in both indoor and outdoor cultivation. "We believe Hawthorne sales have found the bottom in terms of average daily volume," Miller explained. "However, there is a seasonal element to the business that would normally be in play by now that has not materialized to the extent we anticipated. While sales volume has begun to improve recently, the year-over-year rate of decline has expanded and that trend appears likely to carry through March. The revised Hawthorne sales outlook means ScottsMiracle-Gro is unlikely to reach the low end of its guidance for non-GAAP adjusted earnings per share. Miller said management remains optimistic about the continued strength of the U.S. Consumer segment and is working to moderate the earnings gap from the shortfall in Hawthorne sales with a goal of achieving non-GAAP adjusted earnings per share of at least $8.00. "The midpoint for our sales guidance for our U.S. Consumer business continues to assume an 8-point decline in unit volume on a full-year basis and the business continues to significantly outperform against that plan," Miller said. "Consumer purchases, in units, entering March are essentially flat from year-ago levels and shipments to retailers through five months are at record levels. Still, it is too early in the season to adjust our outlook for the business. However, we and our retail partners remain encouraged by the level of consumer participation we continue to see as we prepare for the peak weeks of the season." During his presentation to investors, Miller also said the Company no longer expects a significant acquisition in fiscal 2022 to bolster its presence in the live goods category. ScottsMiracle-Gro had been actively pursuing such an opportunity over the past year but has ended those discussions. "We see live goods as critical to our future with growth in this category through M&A remaining a major component of our strategic plan," Miller said. "However, our M&A strategy has been successful over the last several years because we have remained disciplined in our approach and been willing to step away when the economics or other factors no longer make sense." The Company expects to provide a further update on May 3, 2022, when it releases its second quarter results.

09:04 EST TrueCar launches its online car buying platform - TrueCar is debuting TrueCar+, its online car buying platform. Using TrueCar+, consumers will be able to explore, confirm and complete their car purchase with a dealer, and arrange financing and delivery from the convenience of home. They will also have the option of completing any portion of the transaction at a TrueCar Certified Dealer, based on their shopping preference.

09:03 EST AMCI Acquisition Corp. II and LanzaTech NZ announce business combination - LanzaTech NZ, a Carbon Capture and Transformation company and AMCI Acquisition Corp. II announced that they have agreed to combine through a business combination transaction. Upon closing of the transaction, the combined company will be renamed LanzaTech Global and its common stock is expected to be listed on Nasdaq under the ticker symbol "LNZA."

09:03 EST Emerita Resources provides update on permitting process for Romanera, El Cura - Emerita Resources announces that the permitting for the Romanera and El Cura deposit diamond drill program at its wholly owned Iberia Belt West Project is nearing the conclusion and the Company expects to be able to commence the drill program on those targets in the coming weeks. According to David Gower, P.Geo., CEO of Emerita, "Our entire team is excited to get the drills turning to delineate these two deposits and particularly Romanera. As noted in the Company's news release dated January 28, 2022, recent work by the Company appears to have greatly expanded the potential footprint of the deposit. Whereas historical drilling delineated mineralization along a strike length of 450 meters, our geophysical survey indicates a strong EM conductor that extends for a total strike length of 1,200 meters. On February 18, 2022, the 30 business day period for public comment with respect to the proposed drill program concluded. On the last day of the public comment period, as has been the case previously, there was a submission from Ecologists in Action, a Spanish environmental group. The comments received from the ecologist group are similar to those that were submitted by them to the Provincial Mining Authorities when Emerita received the Iberia Belt West exploration permits. The concerns were addressed at that time and the Project was approved by the authorities and it is the expectation of the Company that the Provincial Environmental Authorities will respond in the same way at this time. From this point, the permitting process requires that the Environmental Authorities consider the comments and provide a response. The Environmental Department is currently drafting the Environmental Statement, which is the basis for the future Unified Environmental Authorization. Once complete, the Environmental Statement is provided to all interested parties for 15 working days for informational purposes and will be followed by the final approval of the Resolution which allows drilling to commence at the Romanera and El Cura deposits. The Romanera and El Cura deposits are part of the IBW Project area that require a comprehensive permitting process due to sensitivity related to the presence of cork oak trees in the area. The Company along with its consultants and in consultation with officials from the Environmental Authorities completed detailed studies, including flora and fauna and archeological studies as part of the process. The drill program has been designed carefully to minimize the footprint and utilize existing roads and farm tracks for the positioning of the drill pads. The file contains all the institutional reports and comments of interested parties, town planning reports from the councils of Puebla de Guzman and Paymogo municipalities, Water, Heritage and Mine/Geology reports, as well as the comments of interested parties, including Ecologists in Action. Drilling continues in the Infanta area of the Project with five diamond drills. Staffing levels continue to be affected by Covid Protocols, which has resulted in staff shortages presently due to the requirement to isolate. The Company is awaiting assays, however massive and semi massive to stringer sulphide mineralization has been intersected at the Infanta North target. Infanta North is a new discovery in that two drill holes have intersected sulphide mineralization over a strike length of at least 300 meters and at a depth of more than 300 meters in an area that has never been drilled previously. A third hole is in progress on this target. Infanta North appears to be in the same stratigraphic and structural position as the El Cura deposit and is interpreted to be a folded repetition of the Infanta stratigraphy to the south. Drilling also continues to extend the sulphide mineralization down dip at the Infanta deposit. The Company will provide a more detailed description of the drill results as soon as assays are received. At Nuevo Tintillo, the helicopter airborne gravity and electromagnetic surveying is about to commence. The company has engaged Geognosia, a geophysical consulting company based in Spain, to carry out the Gravimetric survey, using a Helicopter-borne HTDEM System. The penetration is estimated to be approximately 500m. The company expects this program will results in geophysical anomalies that will be follow up with detailed exploration. The entire property which extends approximately 23 km in an east-west direction by 3 to 5 km north-south will be covered. The line spacing on the western part of the property where the historical mines and the central area where known mineralization occurs will be covered by 100 m spaced lines and the remainder at 200 m line spacing. The Company continues to await the next step of the Aznalcollar legal proceedings for both the Criminal court and the Administrative Court. Due to the numerous disruptions over the past two years related to the pandemic, there is a large backlog of court cases in the system. The Government has indicated it intends to appoint as many as 40 new judges to assist in alleviating this. The Company has received many inquiries from stakeholders regarding the status of Aznalcollar proceedings and counsel in Spain has advised us that these are Superior court proceedings that under the circumstances will be dealt with in time along with the many other cases before the courts. The evidence and the rulings to date all point to a positive outcome for Emerita and that has not changed.

09:00 EST Guardant Health announces Medicare coverage for Guardant360 TissueNext - Guardant Health announced that Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostics Services program, or MolDX, has conveyed coverage for Guardant360 TissueNext under the existing local coverage determination. Guardant360 TissueNext is the company's first tissue-based test to help oncologists identify patients with advanced cancer who may benefit from biomarker-informed treatment.

08:56 EST AgriFORCE announces planned convertible debt facility up to $20M - AgriFORCE Growing Systems announced it has executed a non-binding term sheet for a planned convertible debt facility of up to $20 million with an accredited institutional investor. The Notes would be convertible at $2.75 per share. Under the agreement, the Company would receive an initial amount of $10 million and would have the right to receive an additional $10 million at the Company's discretion, in one or multiple tranches, subject to certain conditions. In addition, the Investor would receive 3-year warrants equal to 50% of the principal Note amount at an exercise price of $2.75 per share, subject to customary adjustments. The Company intends to use the net proceeds of the Notes towards the closing of the previously announced acquisition of Delphy Groep. The Convertible Debt facility term sheet is subject to execution of a final definitive agreement.

08:52 EST Vintage Wine Estates announces $30M stock and warrant repurchase authorization - Vintage Wine Estates announced that its Board of Directors has authorized the repurchase of up to $30M in aggregate value of the Company's common stock and/or warrants through September 8. Pat Roney, Chief Executive Officer, commented, "We are executing well on our multi-channel strategy, driving growth, strengthening profitability and delivering value. We believe VWE's common stock and warrants currently represent a very compelling value, and it makes sense to allocate some capital to repurchases. Given our financial flexibility, this authorization reflects the Board's confidence in our strategy and potential of our business."

08:45 EST Sypris wins sole-source contract extension for truck drivetrain parts, no terms - Sypris Technologies announced that it has entered into a long-term, sole-source contract extension to provide drivetrain components for use in the production of medium and heavy-duty commercial vehicles, effective for shipments beginning in the first quarter of 2022. In addition, the Company was awarded a new program to supply components for use in the production of side-by-side all-terrain vehicles. Terms of the agreements were not disclosed. The components produced by Sypris for use in the drivetrain of medium and heavy-duty trucks are essential to the performance of both the drive and the steer axles of the vehicles. The award of the contract extension is timely for the commercial vehicle market, which is in the midst of a multi-year expansion. The production of heavy-duty vehicles increased 23.4% in 2021, while the outlook for 2022 and 2023 includes additional growth of 13.4% and 21.1%, respectively, according to ACT Research. Commenting on the announcement, Paul Larochelle, Vice President & General Manager of Sypris Technologies stated, "We are pleased to have the opportunity to extend and expand our support for this important customer, the relationship of which has grown substantially over the past 20 years. We will continue to support it with advanced manufacturing systems to ensure that this valued customer continues to benefit from world-class quality, on-time delivery and cost-competitive products."

08:42 EST Jabil to debut new transceiver to expand 'coherent product family' at OFC 2022 - Jabil announced that its Photonics business unit, a provider of customized design, manufacturing and test solutions for optical communications products, is presenting a new transceiver to expand its coherent product family during the OFC 2022 conference and exhibition being held in San Diego, CA from March 8-10. The CFP2 DCO ECO version is a 100/200Gb/s coherent transceiver in a CFP2 form factor supporting both 100Gb/s and 200Gb/s line rates with framing and functionalities geared toward the most recent standardization agreements, including "open Forward Error Correction ." The coherent transceiver has been designed for 100G long haul and 200G metro regional networks. The module is based on Marvel Deneb Coherent digital signal processing and Nokia's CSTAR200+ silicon photonics optical engine to provide best-in-class optical performances and minimum power consumption. The coherent transceiver is compatible with both host systems developed for current 100G/200G modules, in addition to new ones designed for 400G CFP2 DCOs.

08:40 EST Clearmind, SciSparc launch psychedelic pharma collaboration - Clearmind Medicine (CMNDF) announced a Collaboration agreement with SciSparc Ltd. (SPRC). The two companies will explore the potential for the creation of innovative compounds in the psychedelic area. The Collaboration will address, inter alia, examining the benefit of integrating the core technologies of each company by combining molecules from their respective development pipelines. The companies have begun the Collaboration with a joint pre-clinical study and are expecting its results potentially to deepen the Collaboration between the parties. The Collaboration is a "Related Party Transaction" as certain directors and officers of the Company are also or have been directors and officers of SciSparc Ltd. The Company will comply with the Instrument but expects to rely on the exemptions available in Sections 5.5 (a) and 5.7 (a) of the Instrument as they relate to the Collaboration.

08:38 EST MamaMancini's secures new authorizations at Tier-1 national supermarkets - MamaMancini's announced new authorizations and shipments of products into tier-1 national and regional food retailers, club stores and a distributor to a major European airline carrier. MamaMancini's will commence a major rotation joint merchandising program with all 600 Sam's Clubs for its branded 3# Jumbo Meatballs beginning in early April. The Company has also received authorization for a market test of a Panini Sandwich from the Company's T&L Creative Salads division at 200 select Sam's Club Kitchen locations nationally. Major supermarket authorizations include one new item authorized at 1,000 Albertsons and Safeway locations starting in April, and 10 new items authorized at 111 Schnucks Supermarkets in March. "We continued to scale our national network of tier-1 retailer and club store accounts in the first quarter, including the notable addition of T&L Creative Salads products into existing relationships at Sam's Club," said Carl Wolf, Chairman and CEO of MamaMancini's. "This demonstrates the ability to push complementary products through the combined national network. In addition, we secured an exciting new rotational placement with a major European airline carrier for a dinner to be served in-flight - changing the age-old adage about airline food. In the months ahead we will continue to push new products through the combined national distribution network, both from our MamaMancini's classic line as well as through acquired companies. This positions us for an acceleration of robust sales growth starting in the first quarter of this fiscal year. While record high protein prices have certainly affected margins over the last year, we are hopeful that margins will normalize in 2022 as higher prices are passed on to retailers and there is expectations that commodity costs will back off some from these levels. Considering our potential for sales growth and normalized margins, we believe that we can create sustainable value for our valued shareholders," concluded Wolf.

08:37 EST Jones Soda's Fountain Syrup now sold at Costco Business Centers - Jones Soda announced that it has secured a new placement for its Root Beer bag-in-box cane sugar syrup with all Costco Business Centers across the U.S., further expanding the company's presence in the foodservice channel. The listing introduces the Jones fountain beverage program to Costco's large members-only wholesale clientele, including restaurants, bars, convenience stores, offices, and other businesses in need of fountain beverage supplies.

08:36 EST Yield10 Bioscience announces recent advances in development of Camelina - Yield10 Bioscience announced recent advances in the development of Camelina as a platform for the production of PHA bioplastic directly in the seed. Field work completed during 2021 supports the Company's decision to begin seed scale up of prototype PHA spring Camelina lines at acre-scale in 2022. Yield10 is also developing PHA winter Camelina lines and advancing its research program to increase the level and type of PHA production achievable in its Camelina plant varieties. "Camelina holds great promise as a platform crop for efficient, scalable, low-cost production of PHA bioplastics," said Kristi Snell, Ph.D., Chief Science Officer of Yield10 Bioscience. "Through our research and development efforts to date, Yield10 expects to contribute significantly towards the global effort to produce biodegradable materials targeted for consumer packaging and food service items while also helping to reduce the amount of petroleum-based plastic waste currently polluting the world's land and oceans. There is real momentum driving the Company's innovative pace of Camelina PHA trait development and its ultimate commercial deployment for year-round harvest using both spring and winter lines." Yield10 plans to breed an optimized PHA trait into the elite herbicide and disease resistant varieties of Camelina currently advancing in its pipeline with the expectation to process PHA Camelina to achieve the integrated economics of simultaneously producing three seed products: PHA bioplastic, feedstock oil and protein animal feed. Seed based PHA bioplastic would represent a major new market for farmers.

08:34 EST Altra introduces 2024 financial targets, sees path to $3B revenue by 2027 - Altra Industrial Motion will host and webcast its 2022 Investor Day beginning at 10:00 a.m. ET today. During the event, presentations by Chief Executive Officer Carl Christenson, CFO Todd Patriacca, the company's operating company presidents and other members of Altra's senior leadership team will provide an in-depth review of the company's foundational value drivers, review its new 3-pillar strategy for delivering sustainable profitable growth and introduce new three-year long-term financial targets. The company also will demonstrate how it is positioning Altra to be a through-the-cycle compounder with a path to $3B of revenue by leveraging its world-class Altra Business System to drive sustainable margin expansion and strong cash generation that is strategically reinvested to deliver above-market returns. During the event, the team will demonstrate several key themes related to Altra's strength as an investment, including how Altra has: Experienced leadership with demonstrated success improving targeted metrics and managing the business through challenging market environments, A proven and resilient cash generative business model that supports capital allocation priorities of maintaining a healthy balance sheet, investing in growth via organic investments and disciplined M&A, and returning capital to shareholders, A strong and defensible competitive moat with mission-critical solutions and sticky customer relationships, A commitment to maximizing growth by focusing the portfolio and investments on secular trends that leverage core competencies and further advance Altra's product portfolio up the technology curve, and A clear path to further value capture and margin expansion by leveraging our unified Altra Business System with proven Leadership, Growth, & Lean tools. Altra will introduce the following new 2024 financial targets at its 2022 Investor Day: Consistent organic revenue CAGR of 3-5%; 300 basis points of operating margin expansion; Free cash flow conversion above 100%. Altra also is presenting a path to $3 billion of revenue by 2027.

08:32 EST Radius Health announces exclusive extension of MGH collaboration - Radius Health provided an update on business development and intellectual property progress in its Bone Health franchise. Massachusetts General Hospital Research Collaboration On December 15, 2020, Radius announced a discovery research collaboration with Massachusetts General Hospital to evaluate novel oral salt-inducible kinase inhibitors in an array of musculoskeletal diseases. Over the past year, the teams achieved their collective goal of demonstrating skeletal anabolic activity of a candidate oral SIK inhibitor. This tangible progress has provided the foundation for both extending the research collaboration and agreeing to an exclusive license agreement with the objective of progressing a molecule for the treatment of musculoskeletal disorders including, but not limited to, osteoporosis. Dr. Marc Wein M.D., Ph.D., investigator in the Department of Endocrinology at Massachusetts General Hospital with clinical focus on osteoporosis and metabolic bone diseases is the main collaborator with Radius. Dr. Wein's research first described the role of SIKs in mediating the actions of parathyroid hormone in bone. The agreement also incorporates any application beyond musculoskeletal disorders as literature points to significant therapeutic opportunity due to the central role of the SIK pathway in a broad array of diseases. The United States Patent and Trademark Office has granted patent 11,255,842, which extends TYMLOS patent exclusivity to January 10, 2040.

08:29 EST BioNTech, Regeneron expand strategic collaboration for FixVac, Libtayo combo - BioNTech SE (BNTX) announced the expansion of its strategic collaboration with Regeneron (REGN) to advance the Company's FixVac candidate BNT116 in combination with Libtayo, a PD-1 inhibitor, in advanced non-small cell lung cancer. Under the terms of the agreement the companies plan to jointly conduct clinical trials to evaluate their combination in different patient populations with advanced NSCLC. Lung cancer is worldwide one of the most common diagnosed malignant cancer types and the leading cause of cancer death. NSCLC is the most common type of lung cancer, making up about 85% of all lung cancers. The investigational mRNA-based cancer vaccine BNT116 is based on BioNTech's FixVac platform. It consists of a fixed combination of shared tumor-associated antigens that were identified to be frequently expressed in NSCLC. The companies plan to develop the collaboration beginning with Phase 1/2 clinical trials in the first-line treatment setting in advanced NSCLC. Under the terms of the agreement, BioNTech and Regeneron will equally share development costs for the trials. In addition, under a separate agreement, BioNTech plans to conduct and sponsor a Phase 1 clinical trial evaluating the combination of BNT116 and Libtayo in further subpopulations with NSCLC. The agreement follows the company's existing collaboration evaluating the combination of BioNTech's FixVac candidate BNT111 with Libtayo in advanced melanoma. BNT111 was granted U.S. FDA Fast Track Designation in November 2021 and is currently investigated in a randomized Phase 2 trial. The trial was initiated in June 2021, following encouraging data from an exploratory interim analysis of the ongoing Phase 1 Lipo-MERIT study with BNT111 as monotherapy and in combination with PD-1 blockade, which was published in Nature. In addition, BioNTech is investigating and sponsoring a Phase 1 clinical trial evaluating the combination of Libtayo with the Company's FixVac candidate BNT112 in prostate cancer. Libtayo is being jointly developed by Regeneron and Sanofi.

08:29 EST Douglas Elliman director buys $202.6K in common stock - In a regulatory filing, Douglas Elliman disclosed that its director Michael Liebowitz bought 30K shares of common stock on March 4th in a total transaction size of $202.6K.

08:27 EST Aldeyra initiates Phase 2 trial of ADX-2191 - Aldeyra announced that it has initiated a Phase 2 clinical trial of ADX-2191, an investigational new drug product, for the treatment of retinitis pigmentosa, or RP. RP is a clinical group of rare genetic eye diseases characterized by retinal cell death and loss of vision. There are no approved treatments for RP, which affects an estimated 82,000-110,000 individuals in the United States, and approximately 1 in 4,000 people worldwide.

08:26 EST Douglas Elliman CFO buys $101.6K in common stock - In a regulatory filing, Douglas Elliman disclosed that its CFO Bryant Kirkland bought 15K shares of common stock on March 4th in a total transaction size of $101.6K.

08:25 EST Biocept appoints Philippe Marchand as COO - Biocep has appointed Philippe Marchand to the position of COO, effective immediately. Marchand will be responsible for advancing the company's strategic and operational objectives, including all laboratory operations of its CNSide cerebrospinal fluid assay, which helps physicians better detect and manage treatment of patients with metastatic cancers involving the central nervous system. Marchand is a veteran biotechnology executive and scientist with a proven track record in transitioning concepts to implementation and commercialization. Most recently, Marchand was the COO of Biosplice Therapeutics.

08:23 EST Stepstone Group sponsors $102.5M direct lending offering on Mexico's BIVA - StepStone Group announced that on February 18, 2022, it completed the structuring of a USD 102.5 million public offering of a securitized portfolio of direct loans via Certificados Bursatiles Fiduciarios on Mexico's BIVA stock exchange. The securities were priced at USD 105 per certificate, have a maturity of 11 years, carry a coupon of Libor + 2.25% that will be paid semiannually each July and January, and were granted a triple-A rating by HR Ratings. The offering represents the first securitization in Mexico of a portfolio of direct loans granted to North American companies, and it is the first time that StepStone acted as sponsor and manager of a trust issuing a publicly listed rated note in any market. "StepStone is very excited to have designed and structured this innovative security with Mexican insurance companies in mind, as well as other institutional investors that wish to invest in US dollar-denominated securities," said Luis Perezcano, a senior advisor to StepStone.

08:21 EST Revance resubmits DaxibotulinumtoxinA BLA to FDA - Revance announced it has resubmitted its biologics license application, or BLA, to the FDA for DaxibotulinumtoxinA for Injection for the treatment of moderate to severe glabellar lines in response to the Complete Response Letter, or CRL, issued by the FDA in October 2021. The resubmission follows the company's Type A meeting in December 2021 and the subsequent completion of the production of three consecutive drug substance lots and one drug product lot as part of the qualification of a new working cell bank, which was required by the FDA to address the outstanding observations related to the WCB and the drug substance manufacturing process.

08:18 EST Fulgent Genetics authorizes $250M stock repurchase plan - Fulgent Genetics announced that its board of directors has authorized a share repurchase program under which Fulgent may repurchase up to $250M in shares of its common stock.

08:17 EST Global Crossing Airlines announces lease of two A321 aircraft - Global Crossing Airlines announces the signing of an order for the long-term lease of two Airbus A321 Passenger-to-Freighter aircraft from Petrus Aerovista A321 Holdings LLC, a joint venture between Aerovista FZE and Petrus Aviation. The signing was held at the ISTAT Americas Conference in San Diego, which brings together the world's top aircraft lessors, airlines and commercial aviation firms. Aerovista arranged the acquisition of the two Airbus A321 passenger aircraft, and both aircraft will be converted with 321 Precision Conversions. The first aircraft will commence conversion in Q1 2023 and expected to enter service with GlobalX in August 2023. The second aircraft will commence conversion in Q2 2023 and expected to be placed into service by GlobalX in November 2023.

08:16 EST Splash Beverage Group to launch TapouT in 485 Winn Dixie locations - Splash Beverage Group announced Winn Dixie will carry TapouT, its high-performance energy drink in 485 stores located in Alabama, Georgia, parts of Florida and extending into Mississippi and Louisiana. Commenting on the new agreement, Robert Nistico, Splash Beverage Group's Chairman and CEO, said, "We are VERY excited to partner with Winn-Dixie and Southeastern Grocers. This authorization is a key strategic placement as we build out retail distribution throughout the southeast U.S. Winn-Dixie is a premier grocery store chain in the southeast US. TapouT is now being distributed and sold at retail by some of the largest names in the consumer business, including Walmart, Ralph's Stores Budweiser owner AB-ONE, and now Winn-Dixie. This is another important point of retail distribution as we continue to work our distribution and sales strategy ... the more shelves we are on the higher our sales are, it's that simple." Nistico continued, "Splash now has an impressive distribution footprint across the Southeastern portion of the United States as we continue to execute our business plan of expanding distribution depth and availability while constantly innovating and growing SKU count."

08:15 EST Barnes & Noble Education reports Q4 retail gross comparable store sales up 8.4%

08:13 EST NCR acquires fintech intellectual property for Open Banking from Spoke - NCR Corporation announced the acquisition of fintech intellectual property for Open Banking from Spoke Technologies Limited. The acquisition accelerates NCR's move into open and international digital banking - adding data integration capabilities supporting personalization and customer-led experiences that are applicable across Financial Services and supporting the convergence of Finance and Retail for our key clients. "This is another step in our digital banking services growth strategy," said Ismail Amla, Executive Vice President, NCR Corporation. "We are excited about the added value this brings to clients who want to drive digital banking in international markets, enable open banking and to bring together retail and financial experiences for our clients and their customers." "With this acquisition, NCR has the software to embed financial services capabilities into every customer experience and build market-leading data intelligence for their clients," said Andrew Tarver, Founder of Spoke Technologies. This acquisition is consistent with NCR's strategy to acquire intellectual property to enhance established and emerging product capabilities, extending NCR leadership in the vertical industries NCR serves.

08:13 EST Pasithea Therapeutics announces collaboration with The Glimpse Group - Pasithea Therapeutics (KTTA) announced its partnership with The Glimpse Group (VRAR), a Virtual Reality and Augmented Reality platform company and its subsidiary company Foretell Reality. Foretell Reality applies VR technology to various use cases of mental health therapy, support, and human interaction. "We are thrilled to partner with Glimpse to bring VR and AR to patients suffering from mental health disorders. Among its many benefits, VR unites a patient and therapist in a shared environment, which is particularly important in situations where the therapist is remote, such as with our at-home treatment model. VR can also create scenarios to reflect specific traumatic experiences or simulate emotionally loaded conversations. VR is increasingly becoming an innovative clinical tool for patients with specific psychiatric symptoms, which leads to improved patient outcomes, and we look forward to co-developing the program alongside Glimpse," stated Dr. Tiago Reis Marques, CEO of Pasithea Therapeutics. Together with Glimpse, Pasithea will co-develop VR environments to support the treatment of patients with psychiatric disorders in a safe and effective manner.

08:12 EST Ocuphire Pharma completes enrollment in MIRA-4 pediatric safety trial on nyxol - Ocuphire Pharma announced that it has completed enrollment in the MIRA-4 trial evaluating the safety and efficacy of Nyxol eye drops to reverse pharmacologically-induced mydriasis, RM, in 23 pediatric subjects. Ocuphire worked closely with Oculos Development Services and the 2 U.S. investigational sites to accomplish this milestone in 2 months. MIRA-4 is part of a comprehensive MIRA clinical program to develop Nyxol for RM and as agreed with FDA under the Pediatric Research Equity Act. This includes the evaluation in pediatric patients as young as 3 to 11 years old in order to include Nyxol use for this pediatric population. In February, Ocuphire announced completion of enrollment in the MIRA-3 Phase 3 clinical trial investigating Nyxol for RM in adults 18 and older and children of ages 12-17 years. If successful, the company anticipates submission of a New Drug Application to the U.S. Food and Drug Administration for Nyxol for RM in late 2022. Mina Sooch, MBA, CEO and Founder, Ocuphire Pharma commented, "We are building momentum in the first months of 2022 as we report rapid enrollment and completion in three of our late stage trials for Nyxol. If MIRA-4 meets its endpoints, the results would potentially support a broader label for Nyxol in RM to include children as young as age 3. MIRA-3 and MIRA-4 will build upon positive results in the MIRA program and complete the clinical data package for our planned NDA submission to FDA later this year. We expect top-line results from MIRA-3 RM Phase 3 study by end of 1Q22, followed by the LYNX-1 NVD Phase 3 study and MIRA-4 RM pediatric study in 2Q22."

08:12 EST Bragg Gaming granted license in Ontario by AGCO - Bragg Gaming announced that it is among the first iGaming suppliers to have been granted a license by the AGCO, the regulatory agency responsible for the oversight of the modern open and regulated iGaming and sports betting market in Ontario. The license will allow Bragg to supply local iGaming and sports betting operators with its player account management platform, iGaming content and managed services when the market opens on April 4.

08:10 EST Rite Aid says COO Peters , and pharmacy chief Konrad left amid reshuffling - Rite Aid announced steps to realign its management team and streamline the company's operations, including the elimination of the Rite Aid Chief Operating Officer, COO, position and consolidation of its pharmacy leadership. As a result, Jim Peters, COO, and Jocelyn Konrad, Executive Vice President and Chief Pharmacy Officer, have left the company. Karen Staniforth, Senior Vice President, Clinical Pharmacy Services, will take on the title of Chief Pharmacy Officer, which going forward will be focused specifically on centralized pharmacy operations in addition to her current responsibilities. Andre Persaud, Executive Vice President and Chief Retail Officer, will take over field operations for pharmacy as well as oversight of front-end operations. Staniforth, Persaud and Erik Keptner, Senior Vice President and Chief Marketing and Merchandising Officer, will report directly to Heyward Donigan, Rite Aid's President and CEO. In addition, Justin Mennen, Executive Vice President and CIO, will expand his responsibilities to include leadership of all digital and ecommerce and his new title is Chief Digital and Technology Officer.

08:09 EST Satellogic, Astraea collaborate to distribute EO data to Ukrainian government - Satellogic announced a collaboration with Astraea, a geospatial and AI analysis software company, to distribute critical Earth Observation, or EO, data directly to the Ukrainian government, allied governments, and humanitarian organizations on the ground. Satellogic is providing its Daily Collection Access service to the Ukrainian government and allied nations.

08:08 EST GelStat provides update on capital restructuring - GelStat Corporation provided several updates related to its ongoing capital markets activities and corporate initiatives. As previously announced, the Company is in the process of conducting a Regulation A+, Tier 2, equity financing of up to $5 million. Following the commencement of its Public Offering, the Company has successfully recouped over 100 million previously issued shares of common stock as part of a settlement agreement with both former management and a major shareholder. As a result, 100 million shares of common stock have been restored to the Company's treasury and will be available for issuance in the future. GelStat currently has approximately 618 million shares of common stock outstanding, which is an increase from approximately 524 million shares of common stock outstanding prior to commencing its Public Offering. In addition, the Company's Chief Executive Officer and certain members of the GelStat Board of Directors have made purchases of the Company's common stock. The Company plans to provide an exact share count when it files its annual report on Form 1-K for the fiscal year ended December 31, 2021. GelStat expects to provide more regular corporate updates to the market over the coming weeks and months.

08:07 EST Freshworks launches Career ReStart program - Freshworks announced the launch of its Career ReStart program in the US after a successful returnship initiative in India helped to increase gender parity in the technology sector. The program in India kicked off in November 2021, with a goal to find talent in the areas of Sales and Marketing, product management and engineering. After receiving over 1,000 applications, 74 women were shortlisted to complete an interview training workshop. From there, 18 women were selected to complete a 16-week developmental course training S. P. Jain Institute of Management and Research. The training is currently underway and once complete, Freshworks will welcome these ReStart graduates to its workforce. The US program, in partnership with Women Back to Work, seeks to fill Customer Success and Solution Engineer Roles with Career ReStart applicants.

08:05 EST Ayala, MD Anderson Cancer Center, ACC Research initiate AL101 study - Ayala Pharmaceuticals with M.D. Anderson Cancer Center and the Adenoid Cystic Carcinoma, ACC, Research Foundation announce that the first five patients have been enrolled in a "Window of Opportunity" study for individuals with an aggressive, Notch-activated form of Adenoid Cystic Carcinoma. Under the leadership of Dr. Renata Ferrarotto at M.D. Anderson, this study is focused on determining the effects of AL101, a gamma-secretase inhibitor being developed by Ayala for the treatment of ACC and other cancers, on the biology of ACC tumors. In this study, participants will have a biopsy to confirm the diagnosis of ACC with Notch activation and will then receive AL101 for 6 to 8 weeks prior to surgery to remove the tumor. Dr. Roni Mamluk, Chief Executive Officer of Ayala commented, "There is a compelling rationale for the inhibition of the Notch signaling pathway in ACC. We have already demonstrated clinical proof of concept with AL101 in this disease. The goals of this study are to better understand the mechanism of AL101, help us determine the most successful treatment regime, and generate data that will inform the future development strategy."

08:05 EST Greenland Technologies and Princeton NuEnergy announce new partnership - Greenland Technologies Holding announced it entered into a new strategic partnership agreement with Princeton NuEnergy, a technology developer focused on developing second-life battery solutions and closed-loop lithium-ion battery recycling. Under the strategic partnership, the two companies will collaborate to create a safe and sustainable recycling solution for end-of-life lithium-ion batteries used in Greenland's electric industrial vehicles including electric forklifts, electric loaders and electric excavators to further minimize their environmental footprint.

08:03 EST NV5 Global acquires Fulton Consulting Engineers - NV5 Global announced that it has acquired Fulton Consulting Engineers, a provider of mechanical, electrical, plumbing, MEP, design and energy efficiency services through an asset purchase. Fulton strengthens NV5's MEP and technology engineering design and energy efficiency capabilities in California and the Southwest and introduces NV5 to new markets and clients. The acquisition will be immediately accretive to NV5's earnings. "The acquisition of Fulton Consulting Engineers supports NV5's strategic approach to acquisitions by both strengthening our verticals and expanding our high-margin ESG and technology services, and we look forward to the contributions that Fulton will make to our continued growth," said Dickerson Wright, PE, Chairman & CEO of NV5.

08:03 EST Seelos Therapeutics receives letter of CTN from Australian TGA for SLS-005 - Seelos Therapeutics announced it has received an acknowledgement letter of a Clinical Trial Notification, or CTN, from the Australian Government Department of Health Therapeutic Goods Administration, or TGA, for a pilot study of SLS-005, or trehalose injection, 90.5 mg/mL for intravenous infusion, for the treatment of patients with Alzheimer's disease. In addition, Seelos received authorization to conduct a separate open-label basket study in Australia to evaluate the effectiveness of SLS-005 on disease progression and severity, as well as its safety and tolerability, in participants with selected neurodegenerative diseases including Huntington's disease.

07:51 EST Endurance Acquisition Corp trading halted, news pending

07:49 EST CalAmp appoints Brett Jackson as SVP, transportation, logistics - CalAmp announced the promotion of Brett Jackson to senior vice president of transportation and logistics. Jackson will lead CalAmp's transportation and logistics sales team, revenue generation and go-to-market strategy. He will report to Maurizio Iperti, CalAmp's interim Chief Revenue Officer, and focus on bringing fleet operators software-as-a-service solutions that help reduce costs, increase revenue, maximize productivity and keep their fleets safe. Jackson joined CalAmp in 2021, serving as the company's vice president of strategic partnerships.

07:43 EST Marimed adds second retail location in Massachusetts - MariMed announced it signed a definitive agreement to acquire a provisional dispensary license from Green House Naturals. The transaction, which is subject to customary closing conditions and regulatory approvals, will add a second retail location to MariMed's vertically integrated cannabis operations in Massachusetts. Terms of the transaction were not disclosed. The dispensary will be in Beverly, located on the north shore of the Boston metropolitan area, and branded Panacea Wellness. "Adding a second adult-use dispensary in Massachusetts is a key element of our long-term strategic growth plan, continuing our efforts to expand deeper in high-growth states in which we already operate," said Bob Fireman, Chief Executive Officer of MariMed. "We expect the Beverly location to be a particularly strong performer in our growing footprint. We anticipate it will contribute this year to our revenue and Adjusted EBITDA growth, while also strengthening the Panacea Wellness brand in the state." MariMed anticipates the Beverly adult use dispensary will be operational during the second half of 2022. As part of its strategic growth plan, the Company plans to develop a third adult use dispensary in 2022.

07:41 EST Calibre Mining reports exploration drill results from Pan mine in Nevada - Calibre Mining is pleased to announce assay results from the ongoing resource conversion and expansion drill program at the newly acquired, 100% owned Pan mine, located in White Pine County, Nevada. Numerous results outlined below indicate the potential for resource expansion while focusing on converting known zones of mineralization. These reported results are the initial batch from the Q4, 2021 drill program. During 2022, Calibre is advancing an additional multi-rig 50,000 metre program which is currently underway with five drill rigs operating in Nevada. Highlights from the Pan drill program include: Drilling has focused on new zones of mineralization and expanding known zones of inferred mineralization, 1.02 g/t Au over 50.3 metres in Hole PR21-045, 0.83 g/t Au over 34.0 metres in hole PCM21-001; 0.47 g/t Au over 45.7 metres in Hole PR21-044, 0.44 g/t Au over 44.2 metres in Hole PR21-002; 0.46 g/t Au over 56.4 metres and 0.40 g/t Au over 62.5 metres in Hole PR21-001; 0.58 g/t Au over 41.2 metres and 0.68 g/t Au over 24.4 metres in Hole PR21-022; 0.40 g/t Au over 30.5 metres and 0.42 g/t Au over 16.8 metres in Hole PR21-021; 0.65 g/t Au over 9.1 metres in Hole PR21-017, 0.59 g/t Au over 13.7 metres in Hole PR21-048; and 0.48 g/t Au over 45.7 metres in Hole PR21-044, 0.55 g/t Au over 16.8 metres in Hole PR21-056. Darren Hall, President, and Chief Executive Officer of Calibre stated: "These initial results indicate that several targets previously identified by the Nevada exploration team have the potential to add to the overall Pan resource and extend the mine life. Calibre's 2022 drill program will continue to advance near mine resource conversion and expansion opportunities and test new targets that have not been drilled within the Pan exploration concession. The team in Nevada have done a commendable job in establishing Pan as a reliable producer, generating operating cash flow which was prudently reinvested into the business. While it is early, we are seeing the benefits of our muti-rig, 50,000 metre exploration and resource expansion drill program, which will give us valuable new information to optimize the Pan mine production profile. Given Calibre's strong balance sheet and consolidated production guidance of 220,000 - 235,000 ounces gold, the Company will generate significant operating cash flow, providing the capital to reinvest and unlock the ultimate potential at Pan."

07:39 EST Viemed Healthcare board authorizes share repurchase program up to 5% of shares - Viemed Healthcare reported that its Board of Directors has authorized and approved a share repurchase program on Nasdaq. Under the share repurchase program, Viemed may repurchase up to 1,984,014 common shares of the Company from time to time in accordance with applicable securities laws, representing approximately 5% of the total issued and outstanding Common Shares as of March 4, 2022. The Company intends to repurchase Common Shares through open market purchases, block purchases or otherwise in accordance with applicable securities laws. Subject to certain exceptions for block purchases, daily purchases on Nasdaq will be limited to 25% of the average daily trading volume on Nasdaq for the four calendar weeks preceding the date of purchase.

07:39 EST Inozyme appoints Subramanian as CFO, Kim as CTOO - Inozyme Pharma announced the appointment of Sanjay Subramanian as chief financial officer, CFO, effective as of the later of March 21, 2022 and the date immediately following the date of the filing of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2021, and Soojin Kim, Ph.D., as senior vice president and chief technical operations officer, CTOO. Dr. Kim succeeds Inozyme senior vice president and CTOO, Steven Jungles, who has retired from the Company. Subramanian brings to Inozyme over 20 years of corporate finance, capital markets, and business development expertise. Prior to joining Inozyme, Subramanian served as CFO and head of corporate development at Ocugen (OCGN). Kim joins Inozyme with more than 25 years of experience in pharmaceutical research and development and manufacturing. Prior to joining Inozyme, Kim served as senior vice president and site head of the bio plant complex at Hanmi Pharmaceutical.

07:38 EST New Fortress Energy backs commitment to LNG projects amid Sri Lanka outcome - New Fortress Energy issued a statement following a favorable ruling on Friday, March 4, by the Supreme Court of the Democratic Socialist Republic of Sri Lanka . Having considered the merits of all the fundamental rights petitions filed seeking to halt NFE's development of natural gas power solutions in Sri Lanka, the Court fully dismissed the petitions without further hearing. NFE and The Government of the Democratic Socialist Republic of Sri Lanka executed a definitive agreement in September 2021 whereby NFE will invest in energy infrastructure in Sri Lanka and develop a new LNG Terminal off the coast of Colombo. NFE will have gas supply rights to the Kerawalapitya Power Complex and will initially provide GOSL an estimated 1.2 million gallons per day of LNG to supply both the currently operational 310 MW Yugadanavi Power Plant and an additional 350 MW which is expected to commence operations in 2023. The definitive agreement is subject to customary conditions. "We are pleased that the Court has dismissed these petitions, as NFE can now proceed with our plans to deliver cleaner fuels and more reliable, affordable power to Sri Lanka," said Wes Edens, Chairman and CEO of New Fortress Energy. "We look forward to partnering with the Government of Sri Lanka by investing in modern energy infrastructure that paves the way for a sustainable and prosperous future for all Sri Lankans."

07:38 EST Accuray announces first treatments with CyberKnife S7 System - Accuray announced that the CARTI medical care team in Little Rock, Arkansas has treated the first patients in the state using the Accuray CyberKnife S7 System. The entire CyberKnife procedure is typically completed in just 1 to 5 out-patient sessions, providing a shorter overall course of treatment compared to conventional radiation therapy which typically takes 30-40 sessions. The availability of the CyberKnife technology will enable the CARTI team to expand access to precise radiation therapy to patients throughout Arkansas, including those for whom a month or more of travel would have been a barrier to treatment. The CyberKnife platform specializes in delivering stereotactic radiosurgery and stereotactic body radiation therapy, advanced external beam radiation treatment techniques.

07:35 EST Pembina Pipeline receives TSX's approval to renew its NCIB - Pembina Pipeline announced that the Toronto Stock Exchange, or TSX, has approved the renewal of Pembina's normal course issuer bid, or NCIB, to purchase up to 5% of its outstanding common shares. Under the NCIB, purchases of common shares may be made through the facilities of the TSX, the New York Stock Exchange and/or alternative Canadian trading systems, commencing on March 10, and expiring on the earlier of March 9, 2023, and the date on which Pembina has acquired the maximum number of common shares allowable under the NCIB or the date on which Pembina otherwise decides not to make any further repurchases under the NCIB.

07:34 EST Xoma expects cash to be sufficient to fund operations for multiple years - On December 31, 2021, XOMA had cash and restricted cash of $95.4 million. The Company ended December 31, 2020, with cash and restricted cash of $85.8 million. After paying its remaining debt obligations in the second quarter of 2021, XOMA has no debt on its balance sheet. The Company continues to believe its current cash position will be sufficient to fund XOMA's operations for multiple years.

07:33 EST Maverix Metals acquires three royalties projects for $5M - Maverix Metals announced that it has acquired a package of three royalties on gold projects located in Nevada from an indirect, wholly-owned subsidiary of Waterton Precious Metals Fund II Cayman for a $5M cash payment. The three assets are Lewis, Dixie Creek and Railroad. A 3.5% to 4% net smelter return, or NSR, royalty on the Lewis property owned by Gold Standard Ventures. A 4% royalty on 105 claims, covering approximately 846 hectares, including the Dixie Creek prospect, which are currently leased by Gold Standard and form part of the South Railroad project land package. A 4% royalty on 2 claims near the Railroad prospect area, currently leased by Gold Standard, approximately 7 kilometres north of the Pinion deposit on Gold Standard's South Railroad project.

07:24 EST Ondas appoints Gateway Group to oversee investor relations program - Ondas Holdings has appointed Gateway Group, a leading strategic financial communications and capital markets advisory firm, to oversee the Company's expanding investor relations program initiatives. Gateway is partnering with Ondas management to develop and implement a comprehensive outreach and communications program. Activities will include but are not limited to: refining overall company and investment-oriented messaging and corporate positioning; strategic advisory services; and introductions to institutional investors, sell-side analysts and other key contacts in the broader financial community. Gateway will also assist in organizing non-deal roadshows and securing invitations to select financial conferences, including its annual Gateway Conference. In conjunction with Gateway's appointment, Ondas will attend the 34th Annual ROTH Conference, which is being held in-person at the Ritz-Carlton in Laguna Niguel, California from March 13-15, 2022. Ondas Chairman and CEO Eric Brock and President and CFO Derek Reisfield will be holding one-on-one meetings on March 15, 2022.

07:22 EST Lifeist Wellness' CannMart Labs enters supply agreement with SQDC - Lifeist Wellness announced that its wholly owned subsidiary CannMart has established a supply agreement with the SQDC, the sole retail distributor of licensed cannabis products in Quebec, Canada's second most populated province. As a result of this agreement, CannMart now maintains supply agreements with provincial government cannabis control boards and retailing bodies in the provinces of Ontario, Quebec, Alberta, British Columbia, Manitoba, New Brunswick and Saskatchewan, and the Yukon, Northwest Territories and Nunavut territories, constituting access to 95% of Canada's population. CannMart and the SQDC are currently negotiating purchase orders with a view to six SKUs reaching the SQDC's 81 and counting retail stores across Quebec by end of summer 2022.

07:21 EST Travere Therapeutics announces proposed convertible senior notes offering - Travere Therapeutics announced its intention to offer, subject to market and other conditions, $250 million aggregate principal amount of convertible senior notes due 2029 in an underwritten offering. Travere also expects to grant the underwriters of the Notes an option to purchase, for settlement on or before March 31, 2022, up to an additional $37.5 million aggregate principal amount of Notes, solely to cover over-allotments. As described in more detail below, Travere intends to use a portion of the net proceeds from the offering to repurchase a portion of its currently outstanding convertible notes. The Notes will be senior unsecured obligations of Travere and will accrue interest payable semiannually in arrears. The Notes will be convertible in certain circumstances into cash, shares of Travere's common stock, or a combination of cash and shares of Travere's common stock, at Travere's election. The interest rate, initial conversion rate and other terms of the Notes will be determined at the time of the pricing of the offering. Travere intends to use a portion of the net proceeds from the offering to repurchase a portion of its outstanding 2.50% senior convertible notes due 2025 for cash, depending on negotiations and pricing determinations in connection with such proposed repurchase transactions. Travere is negotiating these repurchases with certain of the holders of the 2025 Notes, and no assurance can be given as to how much, if any, of the 2025 Notes will be repurchased or the price at which they will be repurchased. Travere intends to use the remaining net proceeds from the offering for general corporate purposes, which may include clinical trial and other research and development expenses, commercialization expenses, capital expenditures, working capital and general and administrative expenses.

07:18 EST Xos delivers initial vehicles to UniFirst in southern California - Xos (XOS) announced it has delivered three vehicles to UniFirst (UNF) as part of an initial rollout of vehicles purchased by the workwear and textile service company. The three vehicles will be delivered to UniFirst's Southern California location in Santa Fe Springs to be used for customer delivery routes in the region. The Xos vehicles heading to Santa Fe Springs, Calif. are the first out of several that will be delivered to UniFirst locations across the United States. In the second half of 2022, additional vehicles will be delivered to a UniFirst location in Boston, Massachusetts.

07:17 EST Amryt Pharma announces results from PK study for Mycapssa - Amryt announces completion of a successful pharmacokinetic, PK, study for Mycapssa. The data supports a planned Phase 3 study of Mycapssa in the treatment of patients with carcinoid symptoms due to Neuroendocrine Tumors, NET. PK Study Results: The objective of the PK study was to demonstrate that doses of Mycapssa up to 80mg result in the desired bioavailability and dose proportionality with an acceptable safety and tolerability profile. The Phase 1 study was an open-label, six sequence, 3 period cross-over design, enroling 30 healthy subjects who were administered single doses of Mycapssa. The study results showed dose linearity from 20mg to 80mg. Safety and tolerability was acceptable and in line with expectations and no serious adverse events were reported. The study achieved its objectives and the data supports the planned Phase 3 study in patients with carcinoid symptoms due to NET. The study results are consistent with the prior PK study which was undertaken with these higher doses and compared to injectable SSA. The US Food and Drug Administration has confirmed that a single positive Phase 3 study would be sufficient for approval, consistent with the 505(b)(2) regulatory pathway previously agreed. Amryt is currently finalising the study protocol with the FDA and expects to initiate the Phase 3 study in Q4 2022. Dr Joe Wiley, CEO of Amryt Pharma, commented: "Today's news represents a significant milestone in our plan to develop Mycapssa for patients affected by carcinoid symptoms associated with NET. This additional indication for NET, if approved, creates a substantial new market opportunity for Amryt estimated at $1.9B globally. We are very excited at the potential for Mycapssa and our TPE technology to deliver an oral therapy option to NET patients in need".

07:15 EST View Inc. announces Nasdaq grant of stay of delisting, hearing for March 31 - View announced that Nasdaq has granted View a hearing for March 31, 2022, to present its plan to regain compliance with applicable listing requirements. Additionally, the Nasdaq Hearings Panel granted View's request to extend the stay of suspension, which stops the delisting process until Nasdaq has made its determination following the hearing on March 31, 2022.

07:13 EST Acreage announces partnership with botanica to produce Mr. Moxey's THC mints - Acreage announced a licensing agreement with botanica, producer of Mr. Moxey's THC and CBD products, to manufacture and distribute Mr. Moxey's THC mints in Acreage's operating markets as regulations allow. Mr. Moxey's products will be launched in Ohio, New Jersey, Pennsylvania, Illinois, New York, and Maine, which will double Mr. Moxey's consumer reach. Mr. Moxey's artisanal, full-spectrum THC mints are designed to cater to consumers' specific mood states and enhance any occasion. Acreage will manufacture Mr. Moxey's entire line of THC mints in their facilities utilizing botanica's proprietary ingredients, formulas, procedures, and packaging. "Acreage's partnership with botanica not only broadens our diverse selection of top-quality consumer products but also strategically positions us to accelerate growth in our core markets," said Peter Caldini, CEO of Acreage. "Mr. Moxey's has amassed a national following as the best-selling mint in each of their markets, and we are excited to distribute them to our wholesale customers and sell them in our dispensaries."

07:11 EST Verisk, Ford partner to offer standardized, insurance-ready car data in Europe - Verisk (VRSK) announces an agreement with Ford Motor Company (F). As part of the agreement, Verisk can offer standardized, insurance-ready telematics data from connected Ford vehicles in Europe to assist insurers with assessing driving behavior, developing usage-based insurance programs, and potentially rewarding customers who drive safely with discounted rates. This service will be available in the UK, France, Germany, Italy and Spain. The agreement will offer insurers a more accurate view of driver risk and offer consumers the opportunity to receive tailored insurance offerings for their Ford vehicles. With drivers' given consent, insurers will be able to access standardized metrics that Verisk generates from connected Ford vehicles, providing them with valuable insights into their customers' driving behavior.

07:09 EST Telesat announces Intellian to design, supply reference user terminals - Telesat announced a contract award for Intellian to design and supply reference enterprise user terminals for the Telesat Lightspeed Low Earth Orbit, LEO, satellite network. Intellian's satellite terminal technology leverages the company's non-geostationary satellite orbit, NGSO, modem integration and satellite tracking algorithms and will provide Telesat's customers with highly reliable, high throughput access to the Telesat Lightspeed network. Telesat will use early deliveries of Intellian terminals to support system development and performance testing to demonstrate system capabilities. "As a proven terminal provider for Telesat's Phase 1 LEO demonstrations and with their extensive experience in deploying tracking antennas for NGSO networks, Intellian is the right partner to enable customer access to the Telesat Lightspeed network from anywhere in the world," says Aneesh Dalvi, Telesat's Director of LEO Landing Stations and User Terminals. "Intellian's carrier-grade, dual-parabolic terminals will be an integral component of Telesat's low-latency, high-performance Telesat Lightspeed ecosystem."

07:07 EST Cellebrite appoints Rotkopf as chairperson of Ethics & Integrity Committee - Cellebrite announced that Dr. Guy Rotkopf, former Director General of the Israel Ministry of Justice, has been named as the new Chairperson of Cellebrite's Ethics & Integrity Committee. "Dr. Rotkopf brings to the Committee a strong law and academic background," the company said. Founded in August of 2021, the Committee advises the Board of Directors on matters pertaining to evolving international law, ethical considerations related to responsible business practices, and requirements under law and regulations applied to the sale and use of Cellebrite's technologies.

07:05 EST Comscore and WideOrbit expand partnership - Comscore and WideOrbit announced the expansion of their partnership to create the create an automated linear TV buying and selling. Continuing a tradition of innovation, WideOrbit is excited to introduce Comscore TV information to power automated TV transactions and audience targeting across markets and demographics. The partnership facilitates the automated buying and selling of advertising inventory from more than 1700 local TV stations across 210 Local Markets, allowing advertisers to reach a specific number of impressions in a market and/or daypart rather than make specific program buys.

07:03 EST Canadian Solar signs PPA with Axpo Italia - Canadian Solar announced it has signed two 10-year power purchase agreements, or PPA, with Axpo Italia for the purchase of 70% of energy produced by two solar power plants under development totaling 84 MWp. Axpo Italia is one of the largest market operators in the free energy market in Italy and a highly reliable and bankable renewables generator counterparty. The two solar projects of 33 MWp and 51 MWp are located in the central Lazian city of Viterbo, and the western Sicilian city of Trapani, respectively. Canadian Solar is developing both projects, which are planned to start construction before 2023. Axpo Italia will purchase the projects' clean solar electricity after they reach commercial operation in January 2024. Once in operation, the projects are expected to generate approximately 156 GWh of clean energy annually, equivalent to the annual electricity consumption of approximately 61,000 households or displacing 48,500 tons of CO2 emissions.

06:58 EST Lilium signs MoU with NetJets, FlightSafety for proposed partnership - NetJets, a private aviation company, and FlightSafety International, a company that provides professional aviation training, have signed a Memorandum of Understanding, MoU, with Lilium, makers of an all-electric vertical take-off and landing jet, for a proposed strategic partnership. The arrangement would provide NetJets with the right to purchase up to 150 Lilium aircraft, introducing more options to NetJets owners to complement their existing flight patterns. NetJets also anticipates supporting Lilium with a private sales campaign for individuals to purchase Lilium aircraft. In addition, the two companies will explore a business model for the operation of Lilium's network in Florida as well as other regions in the US and Europe. As part of the arrangement, Lilium would also partner with FlightSafety International to provide products and services, such as courseware, industry leading immersive and mixed reality training devices and crew training to support Lilium Jet operations. Daniel Wiegand, Co-Founder and CEO of Lilium said: "This partnership is a major step in our mission to build radically better ways of moving and to electrify regional air travel. We believe that the private and business professional segments will be highly attractive markets in the future and, likewise, early adopters of the eVTOL revolution. We couldn't be happier to collaborate with NetJets and FlightSafety to electrify this market and hope to forge a long-term strategic partnership to bring high speed regional electric air mobility to the world."

06:57 EST Ryder to reshape inbound supply chain for Southern Glazer's Wine & Spirits - Ryder System and Southern Glazer's Wine & Spirits announced that Southern Glazer's has selected Ryder to restructure its inbound transportation and implement one-of-a-kind visibility and collaborative logistics technology RyderShare. The goal: to make Southern Glazer's inbound supply chain more efficient and resilient, which ultimately means its suppliers' products get to market even faster.

06:46 EST Quotient receives CE Mark for its MosaiQ IH Microarray - Quotient announced it has received Conformite Europeenne, or CE, Mark for its MosaiQ Extended Immunohematology, or IH, Microarray. The CE marking confirms the Extended IH Microarray meets the requirements of the European Medical Devices Directive. This allows the Company to commercialize the microarray for use with the Company's MosaiQ instrument across the European Union and other CE Mark recognizing geographies. The Company's MosaiQ platform offers an all-in-one, fully automated, high-performance solution in blood-testing laboratory and other settings. The IH microarray for which the CE mark was just obtained substantially increases the range of tests that can be run on the platform.

06:32 EST Google to acquire Mandiant for $23.00 per share in cash, or $5.4B - Mandiant (MNDT) announced that it has entered into a definitive agreement to be acquired by Google (GOOG, GOOGL) for $23.00 per share in an all-cash transaction valued at approximately $5.4B, inclusive of Mandiant's net cash. The offer price represents a 57% premium to the undisturbed 10-day trailing volume weighted average price as of February 7, the last full trading day prior to published market speculation regarding a potential sale of the company. Upon the close of the acquisition, Mandiant will join Google Cloud. The acquisition is subject to customary closing conditions, including the receipt of Mandiant stockholder and regulatory approvals, and is expected to close later this year.

06:28 EST Google to acquire Mandiant for $23.00 per share, or $5.4B

06:25 EST Kohl's 'disagrees' with Macellum's intent to take control of company - In a regulatory filing on Monday, Kohl's filed a preliminary proxy statement, saying: "We continue to be receptive to all our shareholders' input and continue to evaluate the proposals and perspectives that Macellum has shared. However, we disagree with Macellum's view that 2021 was a 'lost year' given our record results for 2021 and substantial progress achieved on key initiatives. We similarly disagree with Macellum's intent to take control of the Company given the strength and recent refreshment of our Board, our robust strategy and outlook for future value creation, and our Board's commitment to evaluate all ways to create value for shareholders."

06:23 EST ViaSat to outfit Breeze Airways with advanced inflight connectivity - Breeze Airways, the new U.S. low-fare airline founded by aviation entrepreneur David Neeleman, is adding 35 routes this summer from 10 new cities, coast to coast. Breeze, which began service in May, 2021 primarily in the east and southeast of the United States, is now expanding across the U.S. with 77 routes between 28 cities in 18 states. All seats on Breeze's Airbus (EADSY) fleet are fitted with in-seat AC power and USB/C ports. Viasat (VSAT) will outfit Breeze's Airbus A220 fleet with its most advanced in-flight connectivity solution allowing Guests to seamlessly stream TV or movies, check email, browse the internet, and stay connected via social media or messaging apps while inflight. While Breeze will operate the Airbus A220 starting in May, the first aircraft featuring Viasat connectivity is expected to enter service in October 2022.

06:10 EST AltiGen Communications Inc COO Joe Hamblin resigns - Joe Hamblin, Altigen's COO tendered his resignation to pursue other interests. Hamblin joined the company in September 2020 as VP and general manager of Altigen's Teams business unit, prior to moving to his most recent role as COO.

06:07 EST Patterson-UTI announces investment in Criterion Energy Partners - Patterson-UTI announced a strategic investment in Criterion Energy Partners, a geothermal energy development company. Criterion plans to use the proceeds from this investment to advance its first of a kind project in Texas and further execute on its technology development roadmap. Criterion Energy Partners plans to combine existing technology and processes from the drilling of oil and gas wells with proprietary designs to create clean, reliable energy from subsurface heat. Criterion's immediate focus is to deliver direct heat and power to industrial customers in the Texas Gulf Coast.

05:33 EST Shell announces intent to withdraw from Russian oil, gas - Shell announced its intent to withdraw from its involvement in all Russian hydrocarbons, including crude oil, petroleum products, gas and liquefied natural gas, or LNG, in a phased manner, aligned with new government guidance. As an immediate first step, the company will stop all spot purchases of Russian crude oil. It will also shut its service stations, aviation fuels and lubricants operations in Russia. "We are acutely aware that our decision last week to purchase a cargo of Russian crude oil to be refined into products like petrol and diesel - despite being made with security of supplies at the forefront of our thinking - was not the right one and we are sorry. As we have already said, we will commit profits from the limited, remaining amounts of Russian oil we will process to a dedicated fund. We will work with aid partners and humanitarian agencies over the coming days and weeks to determine where the monies from this fund are best placed to alleviate the terrible consequences that this war is having on the people of Ukraine," said Shell CEO, Ben van Beurden. "Our actions to date have been guided by continuous discussions with governments about the need to disentangle society from Russian energy flows, while maintaining energy supplies. Threats today to stop pipeline flows to Europe further illustrate the difficult choices and potential consequences we face as we try to do this. Following government statements this week, I want to set out our position clearly. Unless directed by governments, we will: Immediately stop buying Russian crude oil on the spot market and we will not renew term contracts. At the same time, in close consultation with governments, we are changing our crude oil supply chain to remove Russian volumes. We will do this as fast as possible, but the physical location and availability of alternatives mean this could take weeks to complete and will lead to reduced throughput at some of our refineries. We will shut our service stations, aviation fuels and lubricants operations in Russia. We will consider very carefully the safest way to do this, but the process will start immediately. We will start our phased withdrawal from Russian petroleum products, pipeline gas and LNG. This is a complex challenge. Changing this part of the energy system will require concerted action by governments, energy suppliers and customers, and a transition to other energy supplies will take much longer. These societal challenges highlight the dilemma between putting pressure on the Russian government over its atrocities in Ukraine and ensuring stable, secure energy supplies across Europe," said van Beurden. But ultimately, it is for governments to decide on the incredibly difficult trade-offs that must be made during the war in Ukraine. We will continue to work with them to help manage the potential impacts on the security of energy supplies, particularly in Europe."

05:13 EST DuPont announces multimillion-euro investment in Athlone manufacturing facility - DuPont announced a major transformation of the OxyMem Membrane Aerated Biofilm Reactor, or MABR, at its manufacturing facility in Athlone, Ireland. The investment in the facilities and employees at the Athlone site will help meet the increasing global demand for MABR. OxyMem was the first company to commercialize MABR technology, which provides unique and differentiated performance for secondary wastewater treatment. DuPont acquired OxyMem in 2019, expanding its extensive portfolio of industry-leading water solutions that help produce, purify, and extract products. This multimillion-euro investment includes additional training for staff based in Athlone. This project is supported by the Irish Government through IDA Ireland.

05:08 EST Flywire enters strategic partnership with Tribal Group - Flywire announced a strategic partnership with Tribal Group, a provider of Education Technology SaaS solutions globally. Tribal Group will extend Flywire's digital education payments platform into its student information system, enabling a payment experience for students and administrators in the Europe, Middle East and Africa as well as in the Asia Pacific markets.